The role of notch signaling in the regulation of proliferation and cell differentiation during embryonic and postnatal pituitary development by Goldberg, Leah
THE ROLE OF NOTCH SIGNALING IN THE REGULATION OF PROLIFERATION AND CELL 
DIFFERENTIATION DURING EMBRYONIC AND POSTNATAL PITUITARY DEVELOPMENT 
 
 
 
 
 
 
 
BY 
 
LEAH B. GOLDBERG 
 
 
 
 
 
 
 
 
DISSERTATION 
 
Submitted in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy in Molecular and Integrative Physiology 
in the Graduate College of the 
University of Illinois at Urbana-Champaign, 2014 
 
 
 
 
 
Urbana, Illinois 
 
 
Doctoral Committee: 
 
Associate Professor Lori Raetzman, Chair  
Professor Ann Nardulli  
Professor Phil Newmark 
Assistant Professor Eric Bolton  
  
 
 
 
	  	   ii 
ABSTRACT 
 The pituitary develops in two distinct waves in mice, one occurring during 
embryogenesis and a second taking place during early postnatal development. 
During both periods, progenitor cells proliferate and subsequently differentiate 
into hormone-producing cells. Maintaining the proper number of progenitors and 
producing the appropriate number and type of endocrine cells is essential to 
pituitary development and function. Although signals necessary for initial pituitary 
commitment and those required for pituitary hormone synthesis have been well 
characterized, pathways that regulate progenitor proliferation and cell fate remain 
unclear. Previous studies have implicated the Notch signaling pathway in these 
processes, both in the pituitary and in other developing tissues. In order to more 
specifically define the role of Notch signaling during different stages of pituitary 
development, we utilized pituitary-specific gain- and loss-of-function mouse 
models, in combination with chemical Notch inhibition.  
 Notch signaling is necessary for progenitor maintenance in many systems. 
Additionally, loss of the canonical Notch target Hes1 in combination with loss of 
the pituitary specific Notch target, Prop1, results in premature differentiation of 
corticotropes. Based on these observations, we hypothesized that Notch 
signaling is sufficient to inhibit the differentiation of corticotropes and maintain 
these cells in a progenitor state. To test this hypothesis, we generated mice with 
persistent expression of activated Notch in POMC-expressing cells. We show 
that constitutive Notch expression prevents the differentiation of corticotropes 
and melanotropes, which also contain POMC. These cells instead maintain 
	  	   iii 
progenitor markers. In addition, mRNA levels of transcription factors necessary 
for Pomc expression are downregulated in this model. Cells that aberrantly 
maintain progenitor markers are lost during early postnatal development, 
resulting in dysfunction of the hypothalamic-pituitary-adrenal axis. These findings 
confirm our hypothesis that Notch signaling is sufficient to prevent corticotrope 
differentiation.  
 Previous data have suggested that Notch signaling may be able to 
transcriptionally activate Prop1, which is necessary for Pit1 transcription, which is 
necessary for GH, TSH and Prl synthesis. These findings, in combination with 
the observation that Notch signaling is sufficient to inhibit differentiation of 
POMC-expressing cells, led us to hypothesize that Notch signaling may regulate 
the balance between POMC lineage cells and Prop1/Pit1 lineage cells. 
Additionally, we hypothesized that alterations in Notch signaling may lead to 
changes in proliferation and progenitor maintenance, both well characterized 
roles of Notch. To address these hypotheses, we examined a mouse model with 
loss of Notch2 prior to pituitary induction. In this model, we observe a decrease in 
Pit1-positive cell number and an increase in corticotrope cell number, suggesting 
Notch regulates the choice between these pituitary lineages. Additionally, we 
observe defects in proliferation and progenitor maintenance, but not until after 
birth, indicating Notch2 is dispensable for these functions during embryonic 
development.  Because of this observation, we examined the role of Notch 
signaling during postnatal development using a chemical inhibitor of Notch, which 
was specifically administered during postnatal. We observe an increase in Pomc 
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mRNA, a decrease in Pit1 mRNA and a decrease in the number of proliferating 
cells after Notch inhibition. These findings demonstrate that Notch signaling is an 
important regulator of cell fate and proliferation in the postnatal pituitary. In order 
to identify targets that may be necessary for these functions, microarray analysis 
was performed comparing Notch2 ablated mice to controls. Among the target 
mRNAs that were altered, many have been implicated in cell proliferation and a 
subset are involved in corticotrope cell signaling. These targets will be areas of 
future focus in the Raetzman laboratory. Taken together, these studies have 
defined a role for Notch signaling in the control of cellular proliferation, progenitor 
maintenance and specification during embryonic and postnatal pituitary 
development. 
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CHAPTER 1: Introduction 
The pituitary gland, often referred to as the master gland, is an important 
regulator of many physiological processes including growth, metabolism, fertility 
and the body’s response to stress. The pituitary regulates these processes 
through the release of hormones, which act on target endocrine organs to 
regulate the subsequent release of their hormones. Proper pituitary development 
is necessary for pituitary function and the function of its target organs. 
Inappropriate development of the gland can lead to multiple disorders including 
Cushing’s syndrome, gigantism and combined pituitary hormone deficiency. 
Additionally, pituitary tumors are present in roughly 12% of the population upon 
autopsy, while the presence of clinically apparent tumors is 1:1100 (Daly, et al. 
2006; Fernandez, et al. 2010; Raappana, et al. 2010), indicating the pituitary is 
highly susceptible to defects in proper control of cell proliferation. Because of the 
prevalence of pituitary disease, developing both during embryogenesis and 
during postnatal gland homeostasis, it is of great importance to understand the 
mechanisms and signaling pathways that underlie pituitary cell proliferation and 
differentiation. 
In mice, the pituitary is composed of three lobes: the posterior lobe (PL), 
the anterior lobe (AL), and the intermediate lobe (IL). The posterior lobe, which is 
of neural origin, contains pituicytes and axon terminals of magnocellular neurons. 
The AL contains five hormone-producing cell types: thyrotropes, somatotropes, 
lactotropes, corticotropes and gonadotropes, which produce the hormones 
thyroid stimulating hormone (TSH), growth hormone (GH), prolactin (PRL), 
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adrenocorticotropic hormone (ACTH) and gonadotropins (LH and FSH), 
respectively. The IL contains a sixth hormone-producing cell type, the 
melanotrope. Melanotropes secrete melanocyte-stimulating hormone (αMSH). 
αMSH and ACTH are both cleavage products of the prohormone 
Proopiomelanocortin (POMC) (Zhu, et al. 2007). 
The AL and IL are derived from cells located in hypophyseal placode, 
which is found at the midline of the anterior neural ridge. The hypophyseal 
placode is of ectodermal origin and expresses the transcription factor Foxg1. At 
the earliest stages, the hypophyseal placode is in direct contact with neural 
tissue that will develop into the PL and hypothalamus. This ectoderm invaginates 
at embryonic day (e) 9.0, forming the primordial pituitary. At e11.0, the 
developing pituitary pinches off from the underlying oral ectoderm to form the 
structure known as Rathke’s Pouch (RP). Throughout development, this tissue 
remains in close contact with the neural tissue that makes up the infundibulum 
(Rizzoti. 2010). Signals from this tissue are necessary for pituitary development. 
In fact, genetic ablation of this region in Nkx2.1 knockout mice, results in failure 
of the pituitary to form. This phenotype is likely due, at least in part, to the loss of 
FGF morphogens that are normally secreted by cells in the infundibulum (Kimura, 
et al. 1996) (Figure 1.1).  
RP contains all of the progenitor cells necessary to form the AL and IL 
(Zhu, et al. 2007; Rizzoti. 2010). These progenitor/stem cells express the factors 
SOX2, and later SOX9 (Fauquier, et al. 2008). Using in vivo lineage tracing 
experiments, it has been shown that SOX2 and SOX9-expressing cells can give 
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rise to all of the different cell types of the pituitary. They can carry out this 
function during embryogenesis and, at a lower rate, in adult mice (Andoniadou, et 
al. 2013; Rizzoti, et al. 2013). Several factors have been identified that are 
necessary for the proper proliferation of these progenitors. These signals include 
both extrinsic factors emanating from the surrounding ventral diencephalon and 
oral ectoderm, such as members of the FGF, BMP, SHH and Wnt families, and 
intrinsic pituitary signals,  (Ericson, et al. 1998; Treier, et al. 1998) (Figure 1.1). 
Despite the identification of these signaling pathways, nothing is known about 
how a progenitor cell integrates and translates the signals it receives to alter 
proliferative behavior. 
 At e11.5, progenitor cells begin to undergo cell cycle exit, migrate 
ventrally towards the developing AL and begin to differentiate into hormone 
producing cells (Zhu, et al. 2007; Bilodeau, et al. 2009). Many current models of 
pituitary development propose hormone cells are specified in an ordered fashion, 
with each cell type exiting the cell cycle during a discrete period of time. 
Furthermore, it is widely accepted that cells exiting the cell cycle at the same 
time migrate to the same location in the pituitary. This process is thought to be 
coordinated by opposing gradients of morphogens in the infindibulum and ventral 
diencephalon and the underlying oral ectoderm (Treier, et al. 1998; Ericson, et al. 
1998). However, recent evidence shows that all of the AL hormone cell types exit 
the cell cycle at the same time, with the majority of cells doing so between e11.5 
and e13.5. The IL melanotropes exit the cell cycle shortly thereafter. Additionally, 
there was found to be no correlation between the timing of cell specification and 
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location in the gland (Davis, et al. 2011). Based on these observations, it remains 
unclear how cells in the same location in the pituitary, and therefore exposed to 
the same chemical gradients, are specified to become different cell types. 
Although all hormone cells exit the cell cycle at roughly the same time, 
corticotropes are the first cell type to express markers of terminal differentiation, 
with Pomc mRNA detectable beginning at e11.5 (Japón, et al. 1994). 
Transcription of Pomc is dependent on several transcription factors including 
TPIT (TBX19), a T-box transcription factor. TPIT cooperates with PITX1, a 
homeodomain transcription factor, to regulate transcription of the Pomc gene. It 
does so by binding directly to the Pomc promoter (Lamolet, et al. 2001; Liu, et al. 
2001). Mice deficient for Tpit fail to express POMC, although corticotrope cell 
commitment is unaffected (Pulichino, et al. 2003a; Pulichino, et al. 2003b). 
Similarly, human TBX19 mutations can result in isolated ACTH deficiency, which 
can be attributed to lack of POMC in the pituitary (Pulichino, et al. 2003a; 
Vallette-Kasic, et al. 2004). Additionally, NeuroD1, a basic helix loop helix 
transcription factor, can also bind synergistically with PITX1 to the Pomc 
promoter and activate its transcription. Mice null for Neurod1 show delayed 
expression of ACTH but eventually show normal hormone production, suggesting 
it may not be as critical as TPIT (Poulin, et al. 1997; Lamolet, et al. 2004). Other 
proteins, including the orphan nuclear receptor Nur77, also bind to response 
elements on the Pomc promoter to drive its transcription (Philips, et al. 1997a; 
Philips, et al. 1997b). Conversely, Pomc transcription is inhibited by the 
expression of BMPs (Nudi, et al. 2005), (Figure 1.1). While much is known about 
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the terminal differentiation of these cells, the signals controlling their specification 
remain unclear. Previous data from our lab show that loss of two Notch effector 
genes results in premature differentiation of corticotropes, suggesting Notch 
signaling may play a role in specification of these cells (Himes and Raetzman. 
2009a). 
The common precursor of somatotropes, lactotropes and thyrotropes 
begins to express the protein PIT1 at roughly e12.5. Prophet of Pit1 (PROP1) is 
required for the activation of Pit1 transcription (Nasonkin, et al. 2004). Ames 
Dwarf mice, which lack functional Prop1, show near complete loss of all cells of 
the PIT1 lineage (Gage, et al. 1996). PIT1 acts in concert with other molecules to 
transcriptionally regulate terminal differentiation markers in each of the three cell 
types. In thyrotropes, which are fully differentiated by e15.5, GATA2 acts 
synergistically with PIT1 to drive Tshb transcription (Kashiwabara, et al. 2009). 
Similarly, in lactotropes, which express PRL beginning after birth, PIT1 acts with 
estrogen receptor and Ets-1 to drive Prl transcription (Bradford, et al. 1996). 
Thyroid hormone and retinoic acid, acting through their respective receptors, 
stimulate growth hormone transcription, which is first observed at e17.5 
(Palomino, et al. 1998). In addition, Math3, a downstream target of PIT1, is 
necessary for the expression of growth hormone releasing hormone receptor, 
which allows somatotropes to respond to stimulatory signals from the 
hypothalamus (Zhu, et al. 2006; Zhu, et al. 2007), (Figure 1.1).  
 A gap in knowledge remains regarding how pituitary progenitor cells 
balance proliferation and differentiation. Additionally, although factors involved in 
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regulating terminal differentiation and hormone synthesis in each of the pituitary 
cell types are well characterized, signals necessary for initial cell specification 
remain largely unclear. Based on previous findings in the pituitary and in other 
developing organs, we hypothesize that Notch signaling regulates the balance 
between proliferating progenitors and differentiated cells in the pituitary. 
 Notch signaling is an evolutionarily conserved pathway that is important 
for progenitor maintenance and cell fate choices. Signaling occurs between two 
adjacent cells, one containing the ligand and the other containing the Notch 
receptors. In mammals, there are two families of ligands, the Delta-like (Dll1, Dll3 
and Dll4) and Jagged (Jag1 and Jag2) families, which can bind to the four Notch 
receptors (Notch1-4). Upon binding, a series of cleavages is triggered, that 
ultimately results in the release of the Notch intracellular domain (NICD). A 
member of ADAM metalloprotease family performs the first cleavage, while the 
second is dependent on gamma secretase. Once the NICD is released, it can 
then travel into the nucleus. Here it binds to RBPj, an essential Notch cofactor, 
and other proteins to create a complex, which binds to DNA and activates the 
transcription of target genes. Canonical Notch targets are members of the Hes 
and Hey families of basic helix loop helix transcription factors. These factors 
often repress the transcription of genes necessary for differentiation, thus 
maintaining the cell as a progenitor (Patten, et al. 2003; Kopan and Ilagan. 2009), 
(Figure 1.2).  
In many developmental contexts, Notch signaling is necessary for the 
proliferation of progenitor cells, but is not sufficient alone to direct their 
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proliferation. However, there are select cases in which Notch can promote 
proliferation, such as in cerebellar granule neuron precursors (Solecki, et al. 
2001). Additionally, activated Notch is thought to contribute to cancer initiation in 
patients with T-ALL (T-cell acute lymphoblastic leukemia), a pediatric leukemia 
that is often associated with mutations in NOTCH1 (Pancewicz, et al. 2010).  
In addition to its role in regulating cell proliferation, Notch signaling has 
been shown to be important for cell fate decisions. For example, in the intestine 
Notch signaling biases cells toward an enterocyte fate and away from a secretory 
fate during adulthood (Stanger, et al. 2005). Additionally, in the inner ear, Notch 
signaling controls the balance between hair cells and support cells through a 
mechanism that is thought to involve lateral inhibition. It is hypothesized that hair 
cells upregulate Notch ligands and activate Notch signaling in neighboring cells. 
This activation prevents these adjacent cells from becoming hair cells and biases 
them toward the support cell fate. A reduction in Notch signaling, therefore, 
results in an increase in hair cell number (Lanford, et al. 1999; Daudet and Lewis. 
2005). 
It remains unclear how Notch signaling influences cell fate choice and the 
balance between proliferation and differentiation in the developing pituitary. 
Expression analysis studies show that the receptors Notch2 and Notch3, the 
ligands Dll1 and Jag1 and the Notch effectors Hes1 and Hey1 are all present as 
early as e9.5 in proliferating progenitors. As cells begin to express terminal 
differentiation makers and migrate towards the developing AL, the expression of 
these molecules diminishes (Raetzman, et al. 2004; Zhu, et al. 2006). Several 
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recent studies have used knockout and transgenic mouse models to determine 
the role this pathway plays in pituitary development. Hes1 null mice have 
hypoplastic pituitaries with failure of melanotropes to form (Zhu, et al. 2006; Kita, 
et al. 2007; Raetzman, et al. 2007). This hypoplastic phenotype is a result of a 
decrease in pituitary proliferation observed throughout embryogenesis (Monahan, 
et al. 2009). However, the confounding problem with this study is lack of pituitary 
specificity in the Hes1 knockout, making it impossible to differentiate the pituitary 
from the hypothalamic role of Notch. Additionally, postnatal proliferation is 
decreased in Ames Dwarf mice, which lack functional Prop1 (Prophet of Pit1), a 
putative pituitary specific target of Notch signaling (Ward, et al. 2005; Zhu, et al. 
2006). In these mice, cells of the PIT1 lineage (lactotropes, thyrotropes and 
somatotropes) fail to differentiate, and LH and FSH levels are reduced. However, 
corticotropes are unaffected, indicating their differentiation is likely controlled by 
an alternative mechanism. These phenotypes are also observed in humans with 
mutations in the PROP1 gene (Wu, et al. 1998). Although corticotropes are 
unaffected in Prop1-deficient mice, specification and differentiation of this lineage 
may also involve Notch signaling because in a global knockout of both Hes1 and 
Prop1, accelerated differentiation of corticotropes is observed (Himes and 
Raetzman. 2009b). This phenotype is not observed in either of the single 
mutants and indicates Notch signaling is required to prevent early differentiation 
of these cells. Similarly, if hypothalamic-pituitary biased embryonic stem cells are 
differentiated in culture, Notch needs to be inhibited in order achieve corticotrope 
fate (Suga, et al. 2011). These data suggest Notch signaling is necessary to 
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inhibit the differentiation of corticotropes.  It remains unclear if Notch signaling is 
also sufficient to prevent the differentiation of corticotropes and closely related 
melanotropes, if it can promote proliferation in these cells and the mechanism by 
which Notch signaling executes these diverse actions. These studies are 
important to increase our understanding of the role of Notch signaling in the 
regulation of proliferation and binary cell fate in the pituitary. 
 In addition to the embryonic wave of pituitary proliferation and 
differentiation described in detail above, the pituitary undergoes a second wave 
of proliferation during the first three postnatal weeks in rodents. In rats, during 
this time, the pituitary expands 5-6 fold in volume (Carbajo-Pérez and Watanabe. 
1990). This period of development has only begun to be studied and signaling 
pathways involved in proliferation and subsequent cell differentiation have not yet 
been identified. Additionally, the adult pituitary has a remarkable ability to 
respond to environmental cues and adjust cell number and size according to 
need. For example, after adrenalectomy or gonadectomy, the pituitary 
proliferates due to lack of negative feedback from target organs (Nolan, et al. 
2004; Nolan and Levy. 2006). Similarly, during pregnancy, the pituitary expands 
in anticipation of the increased need for prolactin during lactation (Yin and Arita. 
2000; Carretero, et al. 2003).  
Although postnatal proliferation has been characterized (Carbajo-Pérez 
and Watanabe. 1990; Kominami, et al. 2003; Gremeaux, et al. 2012), the identity 
of the proliferating cell type (s) remains unclear. Differentiated, hormone-
producing cells have the ability to proliferate during these periods, but they do so 
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at a very low rate, making them unlikely to be the sole contributor to pituitary 
growth (Taniguchi, et al. 2000; Taniguchi, et al. 2001; Taniguchi, et al. 2002a; 
Taniguchi, et al. 2002b). Pituitary progenitors are present at this stage, found 
lining the pituitary cleft, a remnant of the lumen of RP, and scattered throughout 
the AL. Although SOX2 expression decreases in cells in the parenchyma of the 
AL as the animal ages, progenitor cells remain surrounding the cleft throughout 
the life of the animal and maintain the ability to generate all pituitary endocrine 
cell types (Fauquier, et al. 2008; Rizzoti, et al. 2013; Andoniadou, et al. 2013). 
Additionally, it is hypothesized that a transit amplifying population is derived from 
these progenitor cells. We hypothesize that these transit amplifying and 
progenitor populations contribute to postnatal pituitary expansion and may be 
activated in response to environmental cues.  
Because these postnatal and adult progenitors face similar fate choices as 
their embryonic counterparts, it is likely that similar signaling pathways will be 
involved. This progenitor population was shown to be enriched in Notch signaling 
components in postnatal mice and inhibition of Notch signaling in dissociated 
pituitary cells or in pituitary cell aggregates results in a decrease in the size and 
proliferation of the progenitor pool. Increased progenitor proliferation and number 
are observed when these cells are treated with Notch ligands (Chen, et al. 2006; 
Tando, et al. 2013). However, neither the mechanism accounting for these 
observations, nor the consequences of a reduction in the progenitor population in 
vivo, were investigated. Based on these findings and its known role in the 
pituitary during embryogenesis, we hypothesize Notch signaling may act to 
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maintain progenitor cells in the postnatal and adult pituitary and thus influences 
pituitary proliferation and cell fate specification. 
Improper pituitary cellular proliferation or differentiation during either the 
embryonic or postnatal period can result in multiple pituitary disorders, including 
combined pituitary hormone deficiency and adenoma formation. It is, therefore, 
critical, to understand mechanisms controlling these processes. We hypothesize 
that Notch controls binary cell fate choice and proliferation during all stages of 
pituitary development. The studies outlined below aim to determine: 1) the role of 
Notch signaling in embryonic corticotrope development using a pituitary-specific 
gain- and loss-of-function approach, 2) if Notch is necessary for proliferation, 
progenitor maintenance and cell fate choice during postnatal pituitary expansion 
and 3) the identity of Notch targets that are important during postnatal pituitary 
development. 
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CHAPTER 2: Persistent Expression of Activated Notch inhibits corticotrope 
and melanotrope differentiation and results in dysfunction of the HPA axis1. 
ABSTRACT 
The hypothalamic-pituitary-adrenal (HPA) axis is an important regulator of 
energy balance, immune function and the body’s response to stress. Signaling 
networks governing the initial specification of corticotropes, a major component 
of this axis, are not fully understood. Loss of function studies indicate that Notch 
signaling may be necessary to repress premature differentiation of corticotropes 
and to promote proliferation of pituitary progenitors. To elucidate whether Notch 
signaling must be suppressed in order for corticotrope differentiation to proceed 
and whether Notch signaling is sufficient to promote corticotrope proliferation, we 
examined the effects of persistent Notch expression in Pomc lineage cells. We 
show that constitutive activation of the Notch cascade inhibits the differentiation 
of both corticotropes and melanotropes and results in the suppression of 
transcription factors required for Pomc expression. Furthermore, persistent Notch 
signaling traps cells in the intermediate lobe of the pituitary in a progenitor state, 
but has no effect on pituitary proliferation. Undifferentiated cells are eliminated in 
the first two postnatal weeks in these mice, resulting in a modest increase in 
CRH expression in the paraventricular nucleus, hypoplastic adrenal glands and 
decreased stress-induced corticosterone levels. Taken together, these findings 
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show that Notch signaling is sufficient to prevent corticotrope and melanotrope 
differentiation, resulting in dysregulation of the HPA axis. 
 
 
INTRODUCTION 
The hypothalamic-pituitary-adrenal (HPA) axis is critical to mediating the 
body’s response to stress. It also functions to regulate many important 
homeostatic processes, including immune response and energy balance. 
Stressors, either immune or environmental, activate the release of corticotropin 
releasing hormone (CRH) from the paraventricular nucleus (PVN) of the 
hypothalamus to the anterior pituitary through the hypothalamo-hypophyseal 
portal system.  CRH release stimulates the anterior pituitary to synthesize and 
release adrenocorticotropic hormone (ACTH), which acts on the adrenal glands 
to trigger the release of cortisol (corticosterone in mice) (Garren. 1968; Vale, et 
al. 1981). Increased cortisol release results in a number of different physiological 
effects, including an increase in glucose production and mobilization and an anti-
inflammatory response (Munck, et al. 1984). In addition to increased glucose 
release, cortisol also exerts negative feedback on both the hypothalamus and 
pituitary, inhibiting further release of CRH and ACTH (Swanson, Simmons. 
1989). Disruption in proper development or function at any level of the HPA axis 
can result in multiple disorders, including Cushing’s syndrome and adrenal 
insufficiency, which are characterized by increased and decreased levels of 
cortisol, respectively (Drouin, et al. 2007). 
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The pituitary, a crucial component of the HPA axis, develops from an 
invagination of the oral ectoderm at embryonic day (e) 8.5 in mice. By e11.5, the 
developing pituitary pinches off from the underlying oral ectoderm, forming the 
structure known as Rathke’s pouch (RP). RP contains all the progenitor cells that 
are necessary for formation of the anterior lobe (AL) and intermediate lobe (IL) of 
the pituitary (Burrows, et al. 1999; Rizzoti, Lovell-Badge. 2005). The AL contains 
five hormone producing cell types, which include thyrotropes, lactotropes, 
gonadotropes, corticotropes, somatotropes, and lactotropes. The IL houses a 
sixth hormone cell type, the melanotropes.  Current models propose that pituitary 
hormone producing cells are specified such that each cell type differentiates 
during a discrete time during embryonic development (Pope, et al. 2006). 
Furthermore, it is widely accepted that cells exiting the cell cycle at the same 
time migrate to the same location in the pituitary (Dasen, Rosenfeld. 2001; 
Wagner, Thomas. 2007). This synchronized cell specification and migration is 
thought to be coordinated by opposing gradients of bone morphogenetic proteins 
(BMPs) in the underlying oral ectoderm and fibroblast growth factors (FGFs) in 
the ventral diencephalon (Ericson, et al. 1998; Treier, et al. 1998). However, 
recent evidence indicates that each AL hormone cell type exits the cell cycle at 
the same time, with the majority of cells doing so between e11.5 and e13.5. 
Furthermore, there is no apparent correlation between the timing of cell 
specification and cell placement within the gland (Davis, et al. 2011). Based on 
these observations, it remains unclear how undifferentiated progenitor cells 
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within the same region of the AL, exposed to the same chemical gradients, are 
specified to become different cell types. 
Although all AL hormone cell types exit the cell cycle at the same time, 
corticotropes are the first to express hormone beginning at e12.5 (Japón, et al. 
1994). Melanotropes, found in the IL, exit the cell cycle after AL hormone 
producing cells and express hormone beginning at e16.5 (Davis, et al. 2011). 
Terminal differentiation of corticotropes and melanotropes is characterized by the 
expression of pro-opiomelanocortin (POMC), a precursor of both ACTH, which is 
released by corticotropes, and melanocyte stimulating hormone (αMSH), which is 
produced by melanotropes.  
Several studies have identified multiple transcription factors that activate 
or inhibit expression of POMC in the pituitary. These include TPIT (TBX19), 
(Lamolet, et al. 2001; Liu, et al. 2001), NEUROD1 (Poulin, et al. 1997; Lamolet, 
et al. 2004), Nur77 (Philips, et al. 1997a; Philips, et al. 1997b) and BMPs (Nudi, 
et al. 2005). While these factors are known to regulate Pomc transcription and 
thus the terminal differentiation of corticotropes and melanotropes, it remains 
unclear which signals are involved in the specification of these cells.  
We hypothesize that the Notch signaling pathway, an essential player in 
progenitor maintenance and cell fate determination in many tissues, may play a 
critical role in the specification of corticotropes and melanotropes.  The Notch 
ligands Delta-like1 and Jagged1, the Notch2 and Notch3 receptors, as well as 
downstream Notch effectors of the Hes and Hey families of genes, are present 
during development in proliferating progenitors in RP. As cells differentiate and 
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migrate towards the developing AL, the expression of these molecules is 
suppressed (Raetzman, et al. 2004; Zhu, et al. 2006).  Additionally, the Notch1 
and Notch2 receptors, as well as Hes and Hey transcription factors, are present 
in pituitary stem cells (Chen, et al. 2005; Chen, et al. 2006).  
Studies have shown that loss of function manipulations of the Notch 
signaling pathway result in defects in corticotrope and melanotrope 
differentiation.  In mice lacking Hes1, a canonical Notch target, Tpit mRNA 
expression was found to be increased (Zhu, et al. 2006), suggesting that Notch 
may be necessary to prevent early expression of this transcription factor. When 
both Prop1, a pituitary specific Notch target, and Hes1 are lost, robust premature 
differentiation of corticotropes is observed (Himes, Raetzman. 2009). A similar, 
but more modest, acceleration of Pomc expression is seen in a pituitary-specific 
knockout of Rbpj, the primary mediator of Notch signaling (Zhu, et al. 2006). 
Taken together, these results suggest Notch signaling is necessary to prevent 
differentiation of corticotropes and may act as a negative regulator of early 
corticotrope specification. We hypothesize that Notch signaling is sufficient to 
prevent the differentiation of corticotropes and melanotropes and that Notch 
expression needs to be extinguished for cell differentiation to proceed.  
In order to address this hypothesis, we examined the effects of persistent 
expression of activated Notch1 in POMC-expressing cells. We find that Notch 
signaling is sufficient to prevent differentiation of these cells, coincident with the 
suppression of the transcription factors Tpit and Neurod1. Additionally, we show 
that these undifferentiated cells maintain progenitor qualities but are eliminated 
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during the first two postnatal weeks. The loss of POMC expression in the pituitary 
results in severely hypoplastic adrenal glands and decreased stress-induced 
corticosterone levels. Our results indicate that Notch signaling is both necessary 
and sufficient to repress corticotrope differentiation and that alterations in Notch 
signaling could result in dysfunction of the HPA axis.  
 
MATERIALS AND METHODS 
Mice 
 RosaNotch floxed mice (Murtaugh, et al. 2003) were purchased from 
Jackson Laboratories (Bar Harbor, ME).  A breeding colony was established and 
progeny were bred to Pomc Cre mice (Balthasar, et al. 2004), also purchased 
from Jackson Laboratories (Bar Harbor, ME).  The resulting progeny all possess 
one RosaNotch floxed allele, with half also expressing Cre recombinase.  To 
genotype the mice, tail biopsies were obtained and DNA was extracted using a 
salt-out method.  PCR for the Pomc and Cre alleles was performed as previously 
described (Himes, Raetzman. 2009).  PCR for the RosaNotch floxed allele was 
performed in a similar manner with the following exceptions.  The primers used to 
detect this allele were 5’-AAA GTC GCT CTG AGT TGT TAT-3’, 5’-TAA GCC 
TGC CCA GAA GAC T-3’ and 5’-GAA AGA CCG CGA AGA GTT T G-3’.  The 
samples underwent 35 cycles of denaturing at 95 C for 30 sec, annealing at 55 C 
for 30 sec, and elongation at 72 C for 60 sec, followed by 72 C for 5 min.  All 
animals were housed in a facility with a 12 hour light-dark cycle and were 
maintained in accordance with the University of Illinois at Urbana-Champaign 
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Institutional Animal Care and Use Committee. 
Immunohistochemistry 
 Mice were sacrificed at e16.5, p1, and p32 and embryos and pituitaries 
were fixed in 3.7% formaldehyde diluted in phosphate buffered saline (PBS). 
Samples were dehydrated through a series of graded ethanol, embedded 
coronally in paraffin, sectioned to a thickness of 6 microns and mounted on 
charged slides. For frozen section preparation used to detect CRH in the 
hypothalamus, p32 control and Tg brains were snap frozen in 2-methylbutane, 
cryoprotected overnight at 4°C in 30% sucrose diluted in PBS, and sectioned at 
14µm. 
Paraffin sections were deparaffinized, rehydrated and washed in PBS. 
Samples were then boiled in hot citrate solution (10uM citrate, pH6) for 10 
minutes and cooled for 10 minutes (for all antibodies except POMC and CRH). 
Following antigen retrieval, samples were blocked in a solution containing 5% 
normal donkey serum diluted in immunohistochemical block which contains 3% 
bovine serum albumin and 0.5% TritonX-100 diluted in PBS. Frozen sections 
were fixed in 4% PFA for 30 mins, washed in PBS prior to application of blocking 
solution. For all immunohistochemistry, blocking was followed by an overnight 
incubation at 4°C with primary antibody diluted in immunohistochemical block. 
Primary antibodies used were raised against the following peptides: POMC 
(1:300, Dako, Carpinteria, CA), Sox2 (1:750, Millipore, Billerica, MA), Pax7 
(1:500, Developmental Studies Hybridoma Bank, Iowa City, IA), ki67 (1:100, 
Dako, Carpinteria, CA), phospho-histone-H3 (1:500 Upstate Cell Signaling 
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Solutions, Lake Placid, NY) and CRH (1:1000, Millipore, Billerica, MA, USA).  
Slides were then incubated with biotin-conjugated rat (ki67), mouse (Pax7) or 
rabbit (POMC, Sox2, phospho-histone-H3) secondary antibody diluted in 
immunohistochemical block for one half hour at room temperature.  This was 
followed by a series of washes and a thirty-minute incubation with a streptavidin-
conjugated cy3 or dylight488 fluorophore. Secondary and streptavidin-conjugated 
antibodies were purchased from Jackson ImmunoResearch (West Grove, PA) 
and were used at a concentration of 1:200.  Slides were counterstained with 4',6-
diamidino-2-phenylindole (DAPI, 1:1000, Sigma, St. Louis, MO) and visualized at 
100x, 200x, or 400x magnification using a Leica DM2560 microscope.  
Photographs were taken using a Retiga 2000R color camera (Q-Imaging, Surrey, 
Canada) and acquired using Q-Capture Pro software (Q-Imaging).  Images were 
processed using Adobe Photoshop CS4 (San José, CA). 
Quantitative Reverse Transcriptase PCR 
RNA was isolated from embryonic and postnatal whole pituitaries using an 
RNAqueous micro kit (Ambion, Austin, TX) as per manufacturers protocol.  For 
p32 pituitaries, 0.5µg of RNA was synthesized into cDNA using the ProtoScript 
M-MuLV First Strand cDNA Synthesis Kit (New England Biolabs, Ipswich, MA). 
For e16.5 and p1 pituitaries, RNA was isolated from individual pituitaries of each 
genotype and the total RNA from each pituitary was converted into cDNA. A no 
enzyme control was also prepared and used as a negative control. For 
quantitative RT-PCR 0.2µL of cDNA from p32 and p1 pituitaries and 0.5µL from 
e16.5 pituitaries was amplified using gene-specific primers and SYBR green mix 
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(Bio-Rad Laboratories, Hercules, CA) on a Bio-Rad MyIQ real-time PCR 
machine. Data were analyzed with the change in cycle threshold (∆Ct) value 
method. Specifically, for each sample, the mean Ct of the gene of interest was 
calculated as a average of the duplicates of that sample. This normalized mean 
was subtracted from the mean Ct for Gapdh to obtain the ΔCt. The ΔΔCt was 
then calculated as the difference between the ΔCt for each Tg and each control 
mouse. The relative fold change of Tg mice as compared to control mice was 
calculated as 2-ΔΔCt. The error bars represent the standard error of the mean of the 
relative fold change. Statistical significance was determined using Student’s t 
test. 
Gene specific primers for real time RT-PCR include: Gapdh forward, GGT GAG 
GCC GGT GCT GAG TAT G; Gapdh reverse, GAC CCG TTT GGC TCC ACC 
CTT C; Hes1 forward, CTC GCT CAC TTC GGA CTC; Hes1 reverse, GTG GGC 
TAG GGA CTT TAC; Hey1 forward, CAC GCC ACT ATG CTC AAT; Hey1 
reverse, CCT TCA CCT CAC TGC TCT G; Hey2 forward, GAT TCC GAG AGT 
GCT TGA C; Hey2 reverse, AGG TGC TGA GAT GAG AGA C; Heyl forward, 
GGA ACA ACA GAG AAT GAA C; Heyl reverse, CAG CAG TAG TGA GTA 
ACC; Pomc forward, GTT ACG GTG GCT TCA TGA CCT C; Pomc reverse, 
CGC GTT CTT GAT GAT GGC GTT C; Tpit forward, GATGCC AAG GAG AGA 
AAC C; Tpit reverse, AGC TTT TCT ATC AAA TTC ACT GA; Neurod1 forward, 
GCCCAGCTTAATGCCATCTTTC; Neurod1 reverese, AGC CAC AGT GGA TTC 
GTT TCC C; Mash1 forward, TGG ACT TTG GAA GCA GGA TGG; Mash1 
reverse, TGA CGT CGT TGG CGA GAA ACA; Myc forward, TGA CCT AAC 
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TCG AGG AGG AGC TGG AAT C; Myc reverse, AAG TTT GAG GCA GTT AAA 
ATT ATG GCT GAA GC. 
Reverse Transcriptase PCR 
RNA and cDNA form p5, p7 and p9 pituitaries were prepared in the same way as 
described above with the exception that 0.33µL of cDNA was amplified. 
Amplification was performed using Pax7 specific primers on a C1000 Thermal 
Cycler (Bio-Rad Laboratories, Hercules, CA). Amplification was visualized using 
an ethidium bromide stained gel. Sequences of primers used: Pax7 forward, 
GCA CAG AGG ACC AAG CTC AC; Pax7 Reverse TGG TGG TGG GGT AGG 
TAG AG. 
Corticosterone Assay and Adrenal Collection 
p32 mice were subjected to one hour of restraint stress in a ventilated 50mL 
conical tube beginning at 1500h. At 1600h, mice were sacrificed using CO2. 
Blood was collected by cardiac puncture and allowed to clot for 30 minutes in 
EDTA-coated tubes. Blood was spun down and plasma was collected and stored 
at -20°C until needed. A corticosterone Enzyme Immunoassay kit (Assay 
Designs, Ann Arbor, MI) was used to measure plasma corticosterone levels as 
per manufacturers protocol. All samples were run in duplicate and statistical 
significance was determined using Student’s t test. Adrenals were dissected from 
p32 male and female mice. They were fixed overnight in 3.7% formaldehyde 
diluted in PBS, washed in PBS and photographed. 
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RESULTS 
NICD expression in melanotropes and corticotropes activates Notch target genes 
 To determine the effect of aberrant Notch activity during corticotrope and 
melanotrope development, we generated a mouse model with persistent 
expression of the activated Notch1 intracellular domain (NICD) in POMC-
expressing cells. This mouse was generated from the mating of a RosaNotch 
floxed mouse (Murtaugh, et al. 2003) to a mouse expressing Cre recombinase 
under the control of the Pomc promoter (Balthasar, et al. 2004). POMC is 
expressed in corticotropes in the AL and in melanotropes in the IL. Additionally, 
POMC is produced by hypothalamic neurons in the arcuate nucleus. However, 
these neurons do not innervate pituitary melanotropes or corticotropes and are 
formed through different mechanisms than pituitary cells (McNay, et al. 
2006)(Oertel, et al. 1982; Léránth, et al. 1983; Mezey, et al. 1984; Kawano, 
Daikoku. 1987; Goudreau, et al. 1995). In the absence of Cre recombinase, a 
stop codon flanked by loxP sites prevents the expression of the single-copy 
NICD construct. However, when Cre recombinase is active, the stop codon is 
excised allowing for the constitutive expression of NICD in Pomc-expressing cells 
(Figure 2.1A). Although Notch1 is not normally expressed during pituitary 
development, studies have shown that the intracellular domains of Notch1 and 
Notch2 can have similar transcriptional activity (Kraman, McCright. 2005).  
Furthermore, Notch1 is expressed in the adult stem cell population (Chen, et al. 
2005; Chen, et al. 2006), indicating it may play a role in cell fate choice or 
maintaining progenitor cells in the adult pituitary. Therefore, it is of interest to 
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determine the effects of persistent Notch1 expression in pituitary cell 
specification during development and in postnatal progenitor maintenance. 
Quantitative RT-PCR for Hes1, Hey1, Hey2 and Heyl was performed on 
RosaNotch/+ (control) and RosaNotch/+; Pomc-Cre (Tg) pituitaries at e16.5 to 
determine if NICD overexpression results in an increase in any of the canonical 
Notch effector genes. The age e16.5 was chosen to begin analysis since it is the 
earliest developmental stage at which POMC expression is present in both 
corticotropes and melanotropes. Our results show that Hes1 mRNA levels are 
unchanged between the two experimental groups. However, Hey1, Hey2, and 
Heyl are all significantly increased in Tg pituitaries as compared to their control 
counterparts (Figure 2.1B). These results indicate that overexpression of Notch 
in pituitary melanotropes and corticotropes is sufficient to produce a modest 
change in Notch effector mRNA levels.  
Persistent expression of activated NICD is sufficient to prevent corticotrope and 
melanotrope terminal differentiation 
 Notch signaling is known to regulate the balance between proliferating 
progenitors and differentiated cells in many endocrine organs. Therefore, 
aberrant Notch signaling could possibly alter the size or morphology of the 
developing pituitary. To detect if any such morphological changes are present in 
Tg mice, control and Tg pituitary sections were stained with hematoxylin and 
eosin. At e16.5, the morphology and size of the control (Figure 2.2A) and Tg 
(Figure 2.2B) pituitaries appear similar, with all three lobes present in both 
experimental groups. The same is true at postnatal day (p) 1, when pituitaries of 
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control (Figure 2.2E) and Tg (Figure 2.2F) mice are histologically 
indistinguishable. Since Notch signaling is also implicated in cell differentiation in 
many tissues, we used immunohistochemistry to examine whether POMC 
expression is affected by persistently activated Notch expression at e16.5 and 
p1. At e16.5, control mice have POMC-positive cells in the IL and scattered 
throughout the AL (Figure 2.2C). At this same age, Tg mice have very few 
POMC-positive cells in either the AL or IL. (Figure 2.2D), indicating their 
differentiation is prevented by expression of NICD. This phenotype persists 
through p1, when almost no cells in the IL or AL of Tg mice are POMC-positive 
(Figure 2.2H), compared to the control (Figure 2.2G). Pomc mRNA levels of 
control and Tg e16.5 pituitaries were measured using quantitative RT-PCR to 
determine if this transcript is altered by persistent NICD expression. Similar to 
immunohistochemical observations, Tg mice have significantly lower levels of 
Pomc mRNA as compared to control littermates (Figure 2.2I). Taken together, 
these data show that constitutive NICD expression in melanotropes and 
corticotropes is sufficient to inhibit their differentiation and imply that it is critical 
that Notch signaling be suppressed in order for corticotrope and melanotrope 
differentiation to proceed.  
Activated Notch inhibits the transcription of factors necessary for POMC 
expression 
To better elucidate the mechanism by which Notch inhibits the 
differentiation of corticotropes and melanotropes, quantitative RT-PCR was used 
to examine the mRNA levels of the transcription factors Tpit, Neurod1 and Mash1 
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in control and Tg mice at e16.5. Tpit and Neurod1 have been shown to play a 
role in the activation of Pomc transcription, whereas Mash1 appears to be 
restricted to Pomc containing cells, although it is not required for Pomc 
transcription (Poulin, et al. 1997; Lamolet, et al. 2001; Liu, et al. 2001; Pulichino, 
et al. 2003a; Pulichino, et al. 2003b; Lamolet, et al. 2004; McNay, et al. 2006). 
Tpit, NeuroD1 and Mash1 all show significantly lower mRNA levels in Tg mice as 
compared to their control counterparts, with Tpit showing the strongest 
suppression (Figure 2.3). Therefore, Notch signaling components may directly or 
indirectly affect the expression of factors important for terminal differentiation of 
corticotropes and melanotropes.  
Undifferentiated IL cells remain SOX2-positive progenitors 
 Given that IL cells fail to differentiate when activated NICD is constitutively 
expressed, we hypothesized that these cells may retain markers of pituitary 
progenitors, such as SOX2 (Fauquier, et al. 2008). In control mice, SOX2-
positive cells are seen in the IL in a thin layer lining the lumen of the pituitary 
(Figure 2.4, A, C, E and G). Conversely, in Tg mice, nearly every cell in the IL is 
positive for SOX2, indicating these cells maintain progenitor cell qualities (Figure 
2.4, B, D, F and H). Pax7 is a putative marker of intermediate pituitary 
progenitors (Hosoyama, et al. 2010) and is expressed throughout the IL in control 
mice at p1 (Figure 2.4I), however a thin layer of cells lining the pituitary cleft are 
mostly Pax7-negative (Figure 2.4 K, M, O).  Based on localization, they likely 
constitute SOX2-positive cells. In Tg mice, Pax7 is also restricted to the IL 
(Figure 2.4J). However, nearly every cell in the IL, including those lining the cleft, 
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expresses Pax7 (Figure 2.4, L, N, P). Taken together, these findings indicate that 
constitutive NICD expression results in an increased progenitor population in the 
IL.  
Activated Notch leads to elimination of undifferentiated melanotropes and 
corticotropes 
Morphology and size of adolescent (p32) control and Tg pituitaries were 
examined using hematoxylin and eosin in order to determine if persistent Notch 
expression affects pituitary morphology at later ages. In control pituitaries, a 
prominent IL is observed surrounding the PL (Figure 2.5A). In contrast, the IL of 
Tg mice is reduced to a single-cell thick layer surrounding the PL (Figure 2.5B). 
The AL and PL look similar in both experimental groups. POMC expression was 
analyzed at p32 to determine if the remaining cells in the IL of adolescent Tg 
mice express terminal differentiation markers. In control mice, nearly every cell in 
the IL expresses POMC (Figure 2.5C). However, in Tg mice, only a handful of 
the residual IL cells are POMC-positive  (Figure 2.5D). In addition, very few 
POMC immunoreactive cells are observed in the AL of Tg mice (Figure 2.5F), as 
compared to control mice (Figure 2.5E). The near complete loss of POMC-
expressing cells was confirmed by quantitative RT-PCR for Pomc, which shows 
dramatically lower levels of Pomc mRNA in Tg mice than in control littermates at 
p32 (Figure 2.5G). We also observe a reduction in Crhr1 mRNA in Tg mice, 
further indicating there is a loss of both melanotropes and corticotropes (data not 
shown). To determine if the corticotropes and melanotropes are able to 
regenerate in older mice, pituitary sections from four-month-old control and Tg 
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mice were stained for POMC. Similarly, almost no POMC expression was 
observed in the AL or IL of Tg mice (data not shown). These results suggest that 
expression of activated Notch results in the elimination of undifferentiated 
melanotropes and corticotropes.  
In order to better elucidate the age at which the elimination of these cells 
occurs, TUNEL staining was performed at e16.5 and p1. No differences were 
observed between control and Tg pituitaries at either age (data not shown). This 
indicates that cell death is not initiated until later postnatal development in Tg 
mice. In order to determine the developmental window where IL cells are 
eliminated, Pax7 RT-PCR was performed on p5, p7, and p9 control and Tg 
pituitaries (Figure 2.5H). Since previous results suggest Pax7 is maintained in 
undifferentiated IL cells in Tg mice (see Figure 2.2J), this approach was an 
effective method to determine the age at which IL cells are no longer present. At 
p5, pituitaries from both control and Tg mice express roughly equal levels of 
Pax7, suggesting NICD-containing cells are still present at this age. By p7, Pax7 
levels in Tg mice appear to be suppressed as compared to control mice. In one 
p7 Tg mouse, Pax7 levels are visibly reduced as compared to control, whereas 
another Tg animal shows near complete loss of Pax7 pituitary mRNA. At p9, all 
Tg pituitaries examined contain no detectable levels of Pax7 mRNA, whereas 
control pituitaries still maintain Pax7 expression. These findings show that 
aberrant expression of NICD results in elimination of NICD-containing cells within 
the first two postnatal weeks.   
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Persistently activated NICD expression in POMC-expressing cells results in HPA 
axis dysfunction 
The effects of NICD expression in corticotropes may be reflected in 
alterations throughout the HPA axis. Development and function of the adrenal 
cortex relies heavily on the release of ACTH from the pituitary (Estivariz, et al. 
1982; Simpson, Waterman. 1988). Therefore, adrenal glands were compared 
between control and Tg adolescent mice at p32. Control mice have visibly larger 
adrenal glands than Tg counterparts in both sexes (Figure 2.5I). To determine 
the functional capabilities of the hypoplastic adrenals in Tg mice, stress-induced 
corticosterone levels were measured. Significant decreases in levels of 
corticosterone are observed in both male and female Tg mice as compared to 
control counterparts (Figure 2.5J).  
Under normal conditions, both corticosterone released from the adrenal 
gland and ACTH released from the pituitary can influence CRH release at the 
level of the hypothalamus (Swanson, Simmons. 1989). Given that both 
corticosterone levels and ACTH-positive cells are decreased in Tg mice, we 
would expect that CRH levels in the hypothalamus would be increased as a 
result of positive feedback. To determine differences in CRH expression between 
Tg and control male mice at p32, immunohistochemical expression of CRH was 
examined in the PVN. Tg mice display a slight increase in CRH immunoreactivity 
in the medial parvocellular portion of the PVN (PaMP; Figure 2.6A), a region 
known to be highly responsive to stress (Renard, et al. 2010). As expected, 
without colchicine pretreatment to inhibit axonal transport of peptides, CRH-
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positive cell bodies in control animals are hardly detectable, with some 
immunopositive processes present. In contrast, Tg animals display 
immunoreactive CRH-positive cell bodies as well as neuronal processes, 
indicating an increased level of CRH in this region (Figure 2.6B). These data are 
consistent with CRH localization in Pomc knockout mice (Yaswen, et al. 1999; 
Smart, et al. 2007) and, taken together with the decreased levels of 
corticosterone, show that Notch-induced loss of POMC expression in the pituitary 
leads to subsequent dysfunction of the HPA axis. 
Activated NICD in melanotropes and corticotropes is not sufficient to promote 
their proliferation 
Because Notch is known to promote proliferation in many cell types 
(Solecki, et al. 2001; Collesi, et al. 2008; Zhang, et al. 2008), we hypothesized it 
may have a similar role in corticotropes and melanotropes. We, therefore, 
examined the expression of proliferation markers in p1 control and Tg pituitaries. 
Ki67, a marker of all stages of the cell cycle, is observed throughout the AL, IL 
and PL in control mice (Figure 2.7A). No difference in expression pattern was 
observed in Tg mice (Figure 2.7B), indicating overall proliferation in Pomc-
expressing cells is unaffected by the constitutive expression of NICD. Phospho-
histone-H3 staining was also performed in order to determine if mitosis is altered 
in cells persistently expressing NICD. Again, no visible changes in expression 
were observed between control (Figure 2.7C) and Tg (Figure 2.7D) pituitaries at 
p1. Histological observations were confirmed by quantitative RT-PCR analysis of 
control and Tg p1 pituitaries, which showed no difference in Myc mRNA levels 
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between the two experimental groups (Figure 2.7E). These results indicate that 
activated NICD is insufficient to promote proliferation in undifferentiated Pomc-
expressing cells.  
 
DISCUSSION 
Disruption in normal corticotrope development or function can result in 
various disorders, including isolated ACTH deficiency and Cushing’s syndrome 
(Drouin, et al. 2007). Signals controlling the commitment and specification of 
corticotropes are not well understood, but the Notch signaling pathway has been 
implicated in these processes. We have previously demonstrated that global loss 
of Hes1 and Prop1, two Notch effector genes, results in premature differentiation 
of corticotropes, indicating this pathway is necessary to prevent early 
differentiation of these cells (Himes, Raetzman. 2009). Given this finding, we 
hypothesized that Notch signaling is also sufficient to inhibit the differentiation of 
both corticotropes and closely related melanotropes. Using a mouse model in 
which activated Notch is persistently expressed in these two cell types, we were 
able to confirm this hypothesis. 
As in many developing tissues, Notch signaling components are found in 
RP progenitors and in the adult progenitor population but are excluded from 
differentiated cells (Raetzman, et al. 2004; Zhu, et al. 2006). The presumptive 
pituitary progenitor population also contains the transcription factor SOX2, which 
is thought to be important in maintaining pluripotency and inhibiting cell 
differentiation (Episkopou. 2005; Masui, et al. 2007). SOX2 is expressed in 
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isolated adult murine pituitary progenitors and is mainly localized to a single cell 
layer lining either side of the pituitary cleft in the adult (Rizzoti. 2010). In cochlear 
development, suppression of Notch signaling results in a decrease in the 
expression of SOX2 and in increase in differentiated cells (Dabdoub, et al. 2008). 
It is possible that SOX2 is a direct target of the Notch signaling cascade because 
luciferase reporter assays have shown that NICD has the ability to activate 
transcription of the SOX2 promoter (Ehm, et al. 2010). It is, therefore, not 
surprising that we observe an increase in SOX2 immunoreactivity in pituitary 
cells that contain activated Notch. This increase in SOX2 may correlate with an 
increase in multipotent pituitary progenitor cells, and indicates that Notch 
signaling acts in a similar fashion in the pituitary as it does in other developing 
systems. 
We observed that inappropriately specified cells in the pituitary expressing 
NICD do not reenter the cell cycle and are eliminated during the first two 
postnatal weeks. Persistent expression of activated Notch has been shown to 
induce apoptosis in multiple cell types, including intestinal and neural progenitors 
(Yang, et al. 2004; Fre, et al. 2005). Although we cannot rule out a role for 
activated Notch in inducing apoptosis, it is likely that these cells are eliminated 
because they are undifferentiated. Ames dwarf mice, which lack functional 
Prop1, have extensive apoptosis in aberrantly undifferentiated cells in the 
pituitary at p1 and p8 (Ward, et al. 2005). This data supports the hypothesis that 
undifferentiated pituitary cells may be more prone to cell death, particularly 
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during periods of significant postnatal proliferation  (Carbajo-Pérez, Watanabe. 
1990; Taniguchi, et al. 2002a; Taniguchi, et al. 2002b). 
While Notch signaling in early development is known to influence the 
balance between proliferating progenitors and differentiated cells, it also directs 
cell fate determination at later stages of development in many systems. For 
example, Notch promotes cerebellar granule neuron precursor proliferation 
(Solecki, et al. 2001), but also promotes radial glia differentiation and inhibits 
granule neuron differentiation at later stages of development (Patten, et al. 
2003). A similar dual role of Notch is seen in the intestine where Notch signaling 
inhibits stem cell differentiation during embryogenesis but biases cells toward an 
enterocyte fate and away from a secretory fate during adulthood (Stanger, et al. 
2005). We found that that NICD is not sufficient to convert melanotropes and 
corticotropes to an alternate cell fate but instead traps them in a progenitor fate. 
This is especially clear in the IL where NICD-containing cells do not adopt 
another fate, but rather retain progenitor-like properties. However, since we are 
altering Notch signaling only after cells already committed to become 
melanotropes and corticotropes, it is possible that Notch influences cell fate at a 
different developmental stage as it does in other tissues discussed above. 
Through both gain and loss of function studies, it is clear that Notch can 
influence terminal differentiation of Pomc containing cells (Zhu, et al. 2006; Dutta, 
et al. 2008; Himes, Raetzman. 2009). Molecules required for Pomc transcription, 
and therefore for the terminal differentiation of corticotropes and melanotropes, 
have been well characterized. These factors include TPIT (Liu, et al. 2001; 
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Pulichino, et al. 2003b) and NEUROD1 (Poulin, et al. 1997; Lamolet, et al. 2004). 
In contrast, BMPs have been shown to inhibit the expression of Pomc in vitro 
(Nudi, et al. 2005). While these factors are known to regulate Pomc transcription 
and thus the terminal differentiation of corticotropes and melanotropes, it remains 
unclear which signals are involved in the specification of these cells. Lineage 
specification is likely controlled in part by extrinsic signals, such as morphogens 
expressed in the oral ectoderm and ventral diencephalon surrounding the 
developing pituitary. However, cells located in the same region during 
development do not necessarily develop into the same cell type (Davis, et al. 
2011), suggesting intrinsic properties are also likely involved. We hypothesize 
that Notch signaling may be one such intrinsic factor. We show that persistently 
expressing NICD in corticotropes and melanotropes results in suppression of Tpit 
and Neurod1, indicating their expression may be under the control of the Notch 
signaling cascade. It is also possible that the suppression of these transcription 
factors is a result of the progenitor-like nature of the cells, which are ectopically 
expressing SOX2, and is not a result of their direct regulation by NICD. Future 
studies will be necessary in order to elucidate if and how Notch signaling directly 
regulates these molecules. Taken together with the fact that Prop1, a direct 
transcriptional target of Notch signaling, is required for PIT1 expression and the 
subsequent differentiation of lactotropes, somatotropes, and thyrotropes (Gage, 
et al. 1996a; Gage, et al. 1996b; Zhu, et al. 2006), we propose a model by which 
the Notch signaling pathway regulates the choice between precursors of the 
corticotrope and PIT1 lineages during early pituitary cell specification (Figure 2.8) 
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This study is the first to show that Notch signaling is sufficient to inhibit 
melanotrope and corticotrope differentiation, resulting in loss of these cells and 
subsequent HPA axis dysfunction. This mouse model physiologically resembles 
a Pomc knockout mouse (Yaswen, et al. 1999) and highlights the importance of 
Notch signaling in the regulation of corticotrope ontogeny during HPA axis 
development.  Our study indicates that subtle alterations in Notch signaling within 
POMC lineage cells during early embryonic development can lead to disruption 
of the HPA axis at the level of the hypothalamus, as well as the adrenal gland. 
Disruption of the HPA axis during development has significant physiological 
consequences on the body’s response to stress, and can result in multiple 
disorders, including Cushing’s syndrome and adrenal insufficiency (Drouin, et al. 
2007).  Our findings are not only important to the study of normal pituitary 
development, but also demonstrate how alterations in signaling within 
corticotropes can contribute to dysfunction along the entire HPA axis.   
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Figure 2.1. Persistent expression of NICD results in increases in mRNA levels of Notch targets. (A) 
Construct and mating scheme for activated NICD expression in Pomc-expressing cells. (B) Activated 
NICD results in modest increases in canonical target mRNA levels in Tg (gray bars) pituitaries as 
compared to control (black bars) at e16.5. n=3-5. *:p<0.05.
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Figure 2.2. Persistent NICD expression inhibits the differentiation of melanotropes and corticotropes. 
Coronal sections of control (A) and Tg (B) e16.5 pituitaries were stained with hematoxylin and eosin. No 
differences in morphology were observed between the two groups. POMC immunoreactive cells (red) 
are found in the IL and AL of control (C) pituitaries at e16.5 and are diminished in both lobes of Tg (D) 
mice. Morphology is similar at p1 in control (E) and Tg (F) pituitaries. POMC expression (red) is observed 
in the AL and IL of control mice (G) and is markedly decreased in Tg pituitaries (H) at p1. RT-PCR at 
e16.5 reveals significant decreases in Pomc mRNA in Tg mice as compared to controls (I). Photos 
taken at 200x; Scale bars: 50μm. ****:p<0.0001. n=5-7 (immunohistochemistry) and n=3-5 (qRT-PCR). 
PL=posterior lobe. AL=anterior lobe. IL=intermediate lobe.
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Figure 2.3. Transcription factors regulating Pomc expression are decreased in pituitaries of NICD 
expressing mice at p1. Tpit, Neurod1 and Mash1 mRNA levels are significantly reduced in Tg mice (gray 
bars) as compared to control (black bars) littermates at e16.5 determined by qRT-PCR. * p<0.05. ***: 
p<0.001. n=3-5.
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Figure 2.5. Undifferentiated cells in Tg mice are incompatible with postnatal survival, resulting in 
adrenal dysfunction. Adolescent (p32) pituitaries were stained with hematoxylin and eosin to visualize 
morphology. Control (A) animals have a prominent IL, whereas Tg (B) animals have a very thin layer of 
IL cells (arrow) surrounding the PL. Nearly all of the IL lobe cells are immunoreactive for POMC (red) 
in the control (C) mice. In contrast, very few POMC-positive cells are observed in the IL of Tg mice (D). 
The same is true in the AL where POMC immunoreactive corticotropes are abundant in control mice (E) 
and nearly absent in Tg pituitaries (F). Similarly, qRT-PCR for Pomc reveals a significant decrease in 
Pomc mRNA in Tg adolescent pituitaries (gray bars) as compared to control littermates (black bars) in 
both males and females (G). Pax7 mRNA, which is exclusive to the IL in the pituitary, is present at p5 in 
both experimental groups and decreases dramatically by p9 in Tg pituitaries, indicating IL cells are no 
longer present at this age in Tg animals. Adrenals (I) of Tg males and females are reduced in size as 
compared to control mice. Stress-induced corticosterone levels (J) are significantly decreased in male and 
female Tg mice (gray bars) when compared to control mice (black bars). Photos taken at 100x (A-D) and 
400x (E & F). Scale bars: 50μm (A-F) and 1mm (I). **: p<0.01. ***: p<0.001. ****: p<0.0001. n=3-5 (RT-
PCR), n=5 (immunohistochemistry) and n=4 (corticosterone assay). PL=posterior lobe, AL=anterior lobe, 
IL=intermediate lobe.
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Figure 2.6. Corticotropin releasing hormone (CRH) expression in the paraventricular (PVN) hypothalamus 
of male mice at p32. CRH immunoreactivity appears lower in control mice (A) compared to Tg mice (B) in 
the medial parvocellular portion of the PVN (PaMP). Scale bar: 50μm. n=3.
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Figure 2.7. Proliferation is unaffected by persistent NICD expression. Ki67 immunohistochemistry was 
performed on p1 control (A) and Tg pituitaries (B) and no difference in immunoreactivity (red) was 
observed. Similarly, no difference in Phopho-histone-H3 immunoreactivity (green) was observed between 
control (C) and Tg (D) pituitaries at p1. Nuclei are visualized with DAPI staining (blue; A-D).  Additionally, 
qRT-PCR showed no change in Myc mRNA levels between control and Tg pituitaries at p1 (E). Photos 
taken at 200x. Scale bars: 50μm. n=4-5 (immunohistochemistry) and n=4 (RT-PCR).
Control Tg
A B
C D
R
el
at
iv
e 
Fo
ld
 C
ha
ng
e
Control Tg
E
K
i6
7
P
H
3
0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
56
57
Fi
gu
re
 2
.8
. A
 p
ro
po
se
d 
m
od
el
 fo
r t
he
 ro
le
 o
f N
ot
ch
 s
ig
na
lin
g 
in
 p
itu
ita
ry
 c
el
l s
pe
ci
fic
at
io
n.
 N
ot
ch
 s
ig
na
lin
g 
m
us
t b
e 
re
pr
es
se
d 
fo
r c
or
tic
ot
ro
pe
, m
el
an
ot
ro
pe
 a
nd
 
go
na
do
tro
pe
 d
iff
er
en
tia
tio
n 
to
 o
cc
ur
. I
n 
ad
di
tio
n 
to
 re
pr
es
si
ng
 d
iff
er
en
tia
tio
n,
 N
ot
ch
 s
ig
na
lin
g 
is
 a
ls
o 
ne
ce
ss
ar
y 
fo
r t
he
 a
ct
iv
at
io
n 
of
 P
R
O
P
1,
 w
hi
ch
 is
 re
qu
ire
d 
fo
r 
th
e 
em
er
ge
nc
e 
of
 th
e 
P
IT
1 
lin
ea
ge
. H
es
1,
 a
no
th
er
 N
ot
ch
 e
ffe
ct
or
 m
ol
ec
ul
e,
 is
 n
ec
es
sa
ry
 fo
r t
he
 s
pe
ci
fic
at
io
n 
of
 m
el
an
ot
ro
pe
s.
 
 1
 This chapter has been accepted in its entirety for publication in Molecular Endocrinology. Nantie, L.B., Himes, 
A.D., Getz, D. and Raetzman, L.T., 2014. Notch Signaling in the postnatal pituitary: proliferation, progenitors and 
cell specification. In press.  
 
58 
CHAPTER 3: Notch signaling in postnatal pituitary expansion: proliferation, 
progenitors and cell specification1. 
ABSTRACT 
 Mutations in Prop1 account for up to half of the cases of combined 
pituitary hormone deficiency that result from known causes. Despite this, few 
signaling molecules and pathways that influence Prop1 expression have been 
identified. Notch signaling has been linked to Prop1 expression, but the 
developmental periods during which Notch signaling influences Prop1 and overall 
pituitary development remain unclear. To test the requirement for Notch signaling 
in establishing the normal pituitary hormone milieu, we generated mice with early 
embryonic conditional loss of Notch2 (cKO) and examined the consequences of 
chemical Notch inhibition during early postnatal pituitary maturation. We show 
that loss of Notch2 has little influence on early embryonic pituitary proliferation, 
but is crucial for postnatal progenitor maintenance and proliferation. Additionally, 
we show that Notch signaling is necessary embryonically and postnatally for 
Prop1 expression and robust Pit1 lineage hormone cell expansion, as well as 
repression of the corticotrope lineage. Taken together, our studies identify 
temporal and cell-type specific roles for Notch signaling and highlight the 
importance of this pathway throughout pituitary development.  
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INTRODUCTION 
Hypopituitarism, including combined pituitary hormone deficiency (CPHD), has a 
prevalence of 45.5 per 100,000 individuals (Regal, et al. 2001). Approximately 50% of 
known causes of CPHD result from mutations in the transcription factors PROP1 and 
PIT1 (Cogan, et al. 1998; Wu, et al. 1998; Fluck, et al. 1998; Kelberman, et al. 2009; 
Prince, et al. 2011). PROP1 is necessary for the transcription of PIT1, which is required 
for growth hormone (GH), thyroid stimulating hormone (TSHβ) and prolactin (PRL) 
expression. Therefore, patients with mutations in PROP1, have loss of these hormones. 
Although PROP1 is not necessary for gonadotrope or corticotrope cell differentiation, 
many patients also present with reductions in gonadotropin (LH and FSH) levels and 
acquired adrenocorticotropic (ACTH) deficiency (Pernasetti, et al. 2000; Agarwal, et al. 
2000; Bottner, et al. 2004). Mouse models of Prop1 deficiency have been fundamental 
to our understanding of the etiology of CPHD. Ames Dwarf (Prop1df) mice, which harbor 
a spontaneous point mutation in Prop1, and genetically engineered Prop1null mice both 
recapitulate the phenotype of humans with PROP1 mutations (Sornson, et al. 1996; 
Gage, et al. 1996a; Nasonkin, et al. 2004).  
Although the importance of PROP1 in pituitary development and disease is well 
understood, few genes that regulate PROP1 expression have been elucidated.  
Identifying these factors is important, as mutations in upstream regulators may be 
responsible for additional genetic causes of CPHD. One pathway that has been 
implicated in the control of Prop1 is the Notch signaling pathway. In a mouse model of 
pituitary-specific loss of the essential Notch cofactor, Rbpj, a reduction in Prop1 
transcript, detected by in situ hybridization, is observed. This correlates with reduced 
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expression of Pit1, Gh and Tshb. Furthermore, it was shown that RBPJ can bind to a 
canonical element within the first intron of the Prop1 gene, indicating the control of 
Prop1 by the Notch signaling pathway may be direct (Zhu, et al. 2006). Interestingly, 
Ames Dwarf mice have reduced levels of the receptor Notch2, although increased 
levels of the Dll1 ligand and target Hey1, suggesting that PROP1 may also regulate 
Notch signaling (Raetzman, et al. 2004; Mortensen, et al. 2011). 
The Notch signaling pathway is an evolutionarily conserved pathway that is 
critical to the development of many organs, where its most characterized role is in 
progenitor maintenance. This pathway requires cell-to-cell contact between one cell 
containing the ligand and the other containing the Notch receptor. Activation of the 
cascade in the receptor-containing cell, results in cleavage of the intracellular domain 
(NICD) of the receptor. The NICD can then translocate into the nucleus and, in complex 
with Mastermind-like and RBPJ, drive the transcription of downstream targets. These 
targets are basic helix-loop-helix transcriptional repressors that inhibit the expression of 
pro-differentiation genes, thus maintaining the progenitor state of the cell (reviewed in 
(Kopan and Ilagan. 2009)). Notch2 and Notch3 are expressed in the embryonic pituitary 
and global loss of the Notch effector gene, Hes1, results in reduced proliferation, 
pituitary hypoplasia and loss of αMSH cells in the intermediate lobe (IL) (Raetzman, et 
al. 2004; Zhu, et al. 2006; Raetzman, et al. 2007; Monahan, et al. 2009). In contrast, 
overexpression of Notch receptors can inhibit the differentiation of gonadotropes, 
melanotropes and corticotropes (Raetzman, et al. 2006; Goldberg, et al. 2011). 
However, the contribution of individual Notch receptors during pituitary development, as 
well as the effects of pituitary-specific loss of these receptors, remains unclear. 
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In addition to its expression during embryonic development, Notch signaling 
components are present in the adult pituitary. Expression of these factors are restricted 
to the cells lining the pituitary cleft, which correlates with the localization of adult 
pituitary progenitors (Tando, et al. 2013). In vitro treatment of side population progenitor 
cells from the pituitary of adult mice or dissociated whole pituitary cells from adult rats 
with the Notch inhibitor DAPT, results in a decrease in the number and proliferation of 
progenitor cells. Conversely, in vitro treatment with a soluble Notch ligand, using the 
same experimental systems, results in increased progenitor cell number and 
proliferation (Chen, et al. 2006; Tando, et al. 2013). It is unclear whether similar effects 
would be observed in vivo, as cell-to-cell contact is an important aspect of the Notch 
signaling cascade.   
Studies show that the pituitary undergoes a second wave of proliferation and cell 
differentiation during the first three weeks after birth in rodents, during which it expands 
greatly in size  (Carbajo-Pérez and Watanabe. 1990). Some of this expansion is due to 
increases in cell volume, but progenitor and differentiated cells also proliferate during 
this period  (Taniguchi, et al. 2000; Taniguchi, et al. 2001; Taniguchi, et al. 2002a; 
Taniguchi, et al. 2002b; Gaston-Massuet, et al. 2011). Additionally, the number of 
progenitor cells greatly decreases after postnatal day (p) 21 in mice, indicating these 
cells may play an important role in this phase of expansion (Gremeaux, et al. 2012). 
The constellation of Notch signaling components expressed and whether they are 
important for proliferation and differentiation during this time is unclear. 
In order to further dissect the role of Notch signaling during these critical windows 
of development, we used both genetic and chemical inhibition of Notch signaling 
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throughout early development and specifically during postnatal gland expansion. In 
order to examine the contribution of Notch2 during embryonic pituitary development, we 
generated a mouse with conditional loss of Notch2 (cKO), beginning at embryonic day 
(e) 8.5 in Foxg1-expressing cells  (Wang, et al. 2010). Loss of Notch2 does not appear 
to greatly affect overall embryonic pituitary development, but does result in decreased 
expression of Prop1. Rather, we show that Notch signaling components are highly 
expressed during the early postnatal period and both acute chemical Notch inhibition 
and Notch2 cKO mice display decreases in pituitary proliferation and alterations in 
hormone cell proportions. These changes parallel a substantial decrease in Prop1 
expression. Taken together, these studies further solidify Prop1 as a bona fide Notch 
target and identify a critical role for Notch signaling in postnatal pituitary development. 
Further studies will be necessary to identify whether altered Notch signaling could be a 
contributing factor in CPHD.   
 
MATERIALS AND METHODS 
Mice 
 For Notch signaling pathway component analysis, wildtype mice of mixed genetic 
background were used. For in vitro and in vivo DAPT treatment studies, CD-1 mice 
(Charles River, Wilimington, MA), from a breeding colony maintained in our laboratory, 
were used. For all studies, p1 is considered to be the day of birth. All animals were 
housed in a facility with a 12 hour light-dark cycle and were maintained in accordance 
with the University of Illinois at Urbana-Champaign Institutional Animal Care and Use 
Committee. 
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 In order to generate Notch2 cKO mice, Notch2fl/fl mice (McCright, et al. 2006) 
were obtained from Jackson Laboratory (Bar Harbor, ME) and bred to Foxg1+/cre mice, 
(Hebert and McConnell. 2000) maintained on a 129 background, also purchased from 
Jackson Laboratory. The resulting Notch2+/fl, Foxg1+/cre mice were bred to Notch2+/fl, 
Foxg+/+ littermates to obtain cKO animals. To genotype the mice, tail biopsies were 
obtained and DNA was extracted using a hot shot or salt-out method. PCR for the Cre 
and Notch2 alleles was performed as previously described (Himes and Raetzman. 
2009) using published primer sequences (Hebert and McConnell. 2000; McCright, et al. 
2006). 
DAPT injections 
Beginning at p2, CD1 mice were injected daily for 3 days with 100mg/kg DAPT 
(N-[N-(3,5-Difluorophenacetyl-L-alanyl)]-S-phenylglycine t-Butyl Ester, Gamma 
Secretase Inhibitor IX, Millipore, Billerica, MA) diluted in Dimethyl Sulfoxide (DMSO, 
Sigma-Aldrich, St. Louis, MO) or an equivalent volume of DMSO alone. Pituitaries and 
whole heads were harvested 24h after last injection. For studies examining hormone 
cell fate choice, mice were injected with 100mg/kg DAPT or an equivalent volume of 
DMSO for five days beginning on p3. Pituitaries were harvested on p12, five days after 
last injection. For bromodeoxyuridine (BrdU) studies, mice were injected 
subcutaneously with 0.1mg/g body weight BrdU (Sigma-Aldrich, St. Louis, MO), diluted 
in water, 30 minutes prior to harvest. 
Pituitary explant culture and DAPT washout assay 
Pituitaries were dissected from p3 CD1 mice, rinsed with PBS and transferred to 
a 96 well plate. Culture media was made by adding 1% Penicillin Streptomycin (Fisher, 
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Fairlawn, NJ) and 10% fetal bovine serum (HyClone, Logan, UT) to DMEM/F-12 media 
(Cellgro, Manassas, VA). 10µM DAPT dissolved in DMSO (Millipore) or an equivalent 
amount of DMSO (Cambridge Isotope Laboratories, Andover, MA) was added to the 
culture media from the beginning of culture. After 24h in culture, media was spiked with 
DAPT or DMSO (an equivalent amount to what was added at the beginning of culture) 
and pituitaries were cultured for an additional 24h. For washout assays, media was 
removed from pituitaries, pituitaries were rinsed and DAPT-free, DMSO-containing 
media or 10µM DAPT-containing media was added. Pituitaries were harvested 6h later.  
Immunohistochemistry 
 Whole e12.5 embryos, heads of postnatal mice and pituitaries were fixed in 3.7% 
formaldehyde (Sigma Aldrich, St. Louis, MO) diluted in phosphate buffered saline (PBS) 
and embedded in paraffin for sectioning. Slides were deparaffinized and rehydrated. For 
immunohistochemical detection of SOX2, SOX9, Ki67, PH3, BrdU and Pit1 samples 
were boiled in 10 mM citrate solution, pH6 for 10 minutes and cooled for 15 minutes. 
Next, all samples were blocked in a solution containing 5% normal donkey serum 
(Jackson Immunoresearch, West Grove, PA) diluted in immunohistochemical block, 
which contains 3% bovine serum albumin (Jackson Immunoresearch) and 0.5% 
TritonX-100 (Sigma Aldrich, St. Louis, MO) diluted in PBS. Primary antibodies used 
were raised against the following peptides: SOX2 (1:2000, Millipore, Billerica, MA), 
phospho-histone-H3 (PH3, 1:500, Upstate Cell Signaling Solutions, Lake Placid, NY), 
Ki67 (1:500 BD Biosciences, San Jose, CA) SOX9 (1:500, Millipore, Billerica, MA), Pit1 
(1:4000, kind gift of Dr. Simon Rhodes), POMC (1:1000, DAKO, Carpinteriam, CA), GH, 
TSHβ and LHβ (1:1000, Dr. A.F. Parlow and the National Hormone and Pituitary 
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Program, University of California, Los Angeles) and BrdU (1:200, AbD Serotec, Raleigh, 
NC). Slides were then incubated with biotin-conjugated rat (BrdU), mouse (Ki67) or 
rabbit (Pit1, GH, TSHβ, POMC, LHβ, SOX2, SOX9 and PH3) secondary antibody. This 
was followed by incubation in a streptavidin-conjugated cy3 fluorophore. Biotin and 
streptavidin-conjugated antibodies were purchased from Jackson ImmunoResearch and 
were used at a concentration of 1:500.  Slides were counterstained with 4',6-diamidino-
2-phenylindole (DAPI, 1:1000, Life Technologies, Grand Island, NY) and visualized at 
50x 100x, 200x, or 400x magnification using a Leica DM2560 microscope. Photographs 
were taken using a Retiga 2000R color camera (Q-Imaging, Surrey, Canada) and 
acquired using Q-Capture Pro software (Q-Imaging). Images were processed using 
Adobe Photoshop CS4 (San José, CA). 
Pit1, POMC, LHβ  BrdU quantification 
In order to quantify cells incorporating BrdU, three equally spaced slides 
containing three sections each, were immunohistochemically stained for BrdU. For Pit1, 
POMC and LHβ cell number quantification, 5-6 equally spaced slides containing two 
sections each, were immunohistochemically stained using their respective antibodies. 
For BrdU, the number of positive cells in the AL and IL were counted and the area of the 
AL and IL was measured. For Pit1, POMC and LHβ quantification, the number of 
positive cells in the AL was counted and the area of the AL was measured. Additionally, 
for all cell counts, a ratio of cells per area was determined for each group by counting 
the number of DAPI cells per area. This ratio was used to calculate the total cells in the 
each pituitary section. The number of BrdU-, Pit1-, POMC- or LHβ-positive cells was 
divided by the calculated total cells in each pituitary, giving the percent of 
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immunopositive cells. Statistical significance was determined using Student’s t test. 
AL Volumetric Approximation 
For volumetric approximation, every third slide, containing two sections each, of p6 
control and cKO mice was stained with DAPI. The area of the AL was measured for 
each stained section using ImageJ (NIH, Bethesda, MD). In order to obtain an 
approximation of the AL volume, this area was multiplied by the thickness of the section 
and by three, to account for slides in between stained slides. 
In Situ Hybridization  
Slides were deparaffinized, rehydrated and incubated in PBS containing 0.3% 
triton-X 100 (Sigma-Aldrich, St. Louis, MO) for 10 minutes and permeabilized using 
proteinase K (Life Technologies, Foster City, CA) for fifteen minutes at 37°C. Samples 
were then post-fixed using 3.7% formaldehyde (Sigma-Aldrich) and acetylated for ten 
minutes in a solution containing 0.25% acetic anhydride (Sigma-Aldrich) diluted in 
triethanolamine (Sigma-Aldrich) buffer. Following acetylation, sections were incubated 
in hybridization solution at 55-58°C for a minimum of two hours. DNA Digoxigenin-UTP 
(DIG) labeled probes for the Prop1  (Cushman, et al. 2001), Notch2 (kind gift of Dr. 
Shelley Ross,  Raetzman, et al. 2004)), Hes1 (kind gift of Dr. Ryoichiro Kageyama), 
Hey1 (kind gift of Dr. Mannfred Gessler) or Ghrh (kind gift of Drs. Iain Robinson and 
Paul LeTissier) were denatured and applied to slides for overnight incubation at the 
hybridization temperature. Next, samples were treated with a solution of 50% 
formamide (Sigma-Aldrich) for one hour at the hybridization temperature, followed by 
blocking and then application of anti-DIG Fab fragments for one to two hours at room 
temperature. Slides were then washed, treated with Chromagen buffer solutions of 
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increasing pH and developed at room temperature overnight in Chromagen buffer 
containing NBT/BCIP. Dig-labeled nucleotides, anti-dig antibody and NBT/BCIP were 
purchased from Roche (Mannheim, Germany). 
Quantitative Reverse Transcriptase PCR 
RNA was isolated from embryonic and postnatal whole pituitaries using an 
RNAqueous micro kit (Ambion, Austin, TX) as per manufacturers protocol. For p21 and 
adult pituitaries, 0.5µg of RNA was synthesized into cDNA using the ProtoScript M-
MuLV First Strand cDNA Synthesis Kit (New England Biolabs, Ipswich, MA). For e16.5 
and p1, p5 and p10 and p12 pituitaries, the total amount of RNA from each pituitary was 
converted into cDNA. A no Reverse Transcriptase enzyme control was also prepared 
and used as a negative control. For quantitative RT-PCR 0.1-0.33 µL of cDNA was 
amplified using gene-specific primers and SYBR green mix (Bio-Rad Laboratories, 
Hercules, CA) on a Bio-Rad MyIQ real-time PCR machine. Data were analyzed with the 
change in cycle threshold (∆Ct) value method  (Goldberg, et al. 2011). Statistical 
significance was determined using Student’s t test. For a list of gene specific primers, 
see Table 3.1.  
 
RESULTS 
Loss of Notch2 does not affect proliferation or corticotrope differentiation at e12.5. 
At e12.5, the morphology of the developing pituitary appears similar between 
control (Figure 3.1A) and Notch2 cKO mice (Figure 3.1B). Additionally, proliferation 
appears to be largely unchanged between control (Figure 3.1C) and cKO (Figure 3.1D) 
pituitaries. POMC immunostaining reveals few positives cells in control (Figure 3.1E) 
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and cKO mice (Figure 3.1F), indicating there is no apparent alteration in corticotrope 
number when Notch2 is lost, contrary to what is observed in the Prop1, Hes1 double 
knockout  (Himes and Raetzman. 2009). Because no striking phenotype is observed in 
Notch2 cKO mice, we performed in situ hybridization for Hey1 in control and cKO mice 
to determine if a canonical Notch signaling target is reduced as expected. In control 
mice, at e12.5, Hey1 is expressed throughout the developing pituitary (Figure 3.1G). In 
cKO mice, there is a marked reduction, although not complete loss, of Hey1 expression 
throughout the developing pituitary (Figure 3.1H). Because Notch signaling has been 
shown to potentially regulate Prop1, we examined Prop1 expression in control and cKO 
developing pituitaries. In control mice, Prop1 is expressed throughout Rathke’s pouch 
(RP) and is restricted away from the ventral portion of the developing pituitary where 
differentiated cells are housed (Figure 3.1I). In cKO mice, Prop1 appears to be reduced 
throughout RP (Figure 3.1J). Taken together, these data suggest that Notch2 is not 
necessary for proliferation during early development, but is necessary for Prop1 
expression.  
Characterization of Notch signaling components during postnatal expansion phase of 
pituitary development 
 The pituitary undergoes two distinct waves of cell proliferation and differentiation, 
one occurring during embryogenesis and a second that takes place during the first three 
postnatal weeks in the mouse (Zhu, et al. 2007; Gremeaux, et al. 2012). Although it 
appears Notch2 is not necessary for early pituitary development to proceed normally, 
the role of Notch signaling during the second wave of proliferation and differentiation 
has yet to be elucidated. In order to address this question, we first investigated the 
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spatial and temporal expression patterns of Notch signaling components during this 
critical window to determine if this pathway is active during this time. We used qRT-PCR 
to determine the relative levels of Notch family members during this time (e16.5, p1, p5, 
p10, p21) and compared these levels to those observed in the adult pituitary (Figure 
3.2A-3.2C). These data show that Notch signaling components are present during this 
wave of pituitary expansion and their mRNA levels are, in general, at higher levels than 
those found in adult pituitaries. 
In order to determine the mRNA localization of Notch targets and receptors, we 
performed in situ hybridization for Notch2, Hey1 and Hes1 in p5 coronal sections.  We 
find that Notch2 mRNA is mainly restricted to some, but not all cells surrounding the 
pituitary cleft, particularly in the area where the intermediate and anterior lobes 
intersect. There are also Notch2-positive cells scattered throughout the anterior lobe 
(AL, Figures 3.3A and 3.3B). This expression pattern correlates with the localization of 
the population of pituitary progenitors containing SOX2  (Fauquier, et al. 2008). A 
similar expression pattern is observed for Hey1 (Figures 3.3C and 3.3D), with positive 
cells seen lining the cleft and in scattered cells in the AL. Hes1 appears to be in fewer 
cells than Notch2 and is restricted to the AL side of the pituitary cleft (Figures 3.3E and 
3.2F). Recent studies have shown that PROP1 is also present in cleft cells after birth  
(Garcia-Lavandeira, et al. 2009; Tando, et al. 2013). 
These findings indicate that Notch signaling components are present during early 
postnatal pituitary development and are dynamic, warranting further investigation of the 
role of this signaling pathway during this period. We examined the expression of Notch 
receptors in Notch2 cKO mice at p1 and find that Notch2 is specifically reduced, 
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although not completely lost (Figure 3.3G). Additionally, we find significant reductions in 
mRNA levels of Notch targets, especially Prop1 (Figure 3.3H), making the cKO mouse a 
good model to investigate the effects of loss of Notch2 at this age.  
Notch2 is necessary for the maintenance of pituitary progenitors after birth 
Our analysis shows that Notch2 is maintained in cleft cells after birth, indicating it 
may have a role in progenitor maintenance during the postnatal wave of pituitary 
development. We, therefore, examined SOX2 expression at p1 in control and cKO mice. 
At p1, SOX2 is normally expressed in most cells lining the cleft of the pituitary on both 
the AL and IL sides. In addition, SOX2 is also found in cells scattered throughout the IL 
and the AL. (Figure 3.4A, 3.4C and 3.4E). In cKO mice, none of the cells lining the 
pituitary cleft on the IL side are positive for SOX2. Instead, SOX2-immunoreactive cells 
are found in the dorsal IL, at the IL-posterior lobe (PL) border (Figure 3.4B and 3.4D). 
Interestingly, cells in the AL appear to be largely unaffected in localization or number in 
the cKO (Figure 3.4B and 3.4F). The expression pattern of SOX9, another progenitor 
marker, is similar to that of SOX2. In control mice at p1, SOX9-positive cells are found 
lining the pituitary cleft and scattered throughout the IL and AL, as well as in many cells 
in the PL (Figures 3.4G, 3.4I and 3.4K). In cKO mice, SOX9 is not found in cells lining 
the cleft in the IL, but, similar to SOX2 localization, is restricted to cells in the dorsal IL 
(Figures 3.4H and 3.4J). In addition, in cKO mice, the number of SOX9-immunoreactive 
cells lining the cleft and in the parenchyma of the AL appears to be reduced (Figures 
3.4H and 3.4L, arrows indicate SOX9-negative cleft cells). In support of these 
observations, mRNA levels of Sox2 and Sox9 are both significantly decreased in cKO 
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mice as compared to controls (Figure 3.4M). Taken together, these results show that 
Notch2 is necessary for the maintenance and localization of progenitor cells at p1. 
Loss of Notch2 results in a progressive decrease in pituitary progenitor number 
  To assess whether progenitor cells are maintained in the Notch2 cKO throughout 
early postnatal expansion, we stained p5 control and cKO pituitaries for SOX2 and 
SOX9. In control mice, SOX2 expression in the IL is mostly limited to cells lining the 
cleft (Figure 3.4N and 3.4P). In cKO mice, fewer SOX2-expressing cells remain in the IL 
than what is observed at p1. The cells that do remain are still present at the IL-PL 
border (Figure 3.4O and 3.4Q), rather than lining the cleft. On the AL side of the cleft, 
SOX2 is present in nearly every cell in control mice (Figure 3.4N and 3.4R), and 
appears to be expressed in fewer cells in cKO mice (Figure 3.4O and 3.4S, arrows). In 
addition to SOX2-positive progenitors lining the cleft, there are clusters of SOX2-
expressing cells in the AL parenchyma (Figure 3.4T). Although these clusters are still 
present in cKO mice, they appear to be reduced (Figure 3.4U). In control mice, SOX9 
expression follows a similar pattern in the IL to that of SOX2 (Figure 3.4V and 3.4X). 
Likewise, SOX9 is only expressed in few cells in the IL of cKO and these cells are 
present only in the dorsal IL (Figure 3.4W and 3.4Y). As with SOX2, SOX9 is expressed 
in nearly every cell lining the cleft in the AL in control mice (Figure 3.4V and 3.4Z). 
However, SOX9 expression appears to be lost in many AL cleft cells in cKO mice 
(Figure 3.4W and 3.4A’, arrows). SOX9 is expressed in clusters in the AL parenchyma 
in control mice (Figure 3.4B’). In contrast, very few, if any, clusters are observed in the 
AL parenchyma of cKO mice, and the SOX9-positive cells that are present appear to be 
morphologically different than their control counterparts (Figure 3.4C’). Taken together, 
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these data suggest that Notch2 is necessary to maintain and expand the progenitor 
population during postnatal pituitary maturation.  
Loss of Notch2 results in decreased pituitary proliferation at p1 and decreased AL 
volume at p6 
 Although proliferation is not affected at e12.5 when Notch signaling is reduced, 
we observe a disruption of progenitor cells at p1 and p5. Therefore, we examined 
whether these changes in progenitor cell number and localization correlate with 
changes in postnatal proliferation. In control mice, Ki67-immunoreactive cells are 
observed throughout the AL, IL and PL (Figure 3.5A). In the IL, Ki67 expression is found 
throughout, especially in cells lining the cleft (Figure 3.5C). In cKO mice, there appears 
to be an overall reduction in the number of Ki67-expressing cells in the AL and a striking 
reduction of immunopositive cells in the IL (Figures 3.5B and 3.5D). Additionally, an 
apparent decrease in cells in mitosis is also observed in the cKO as evidenced by a 
reduction in the number of cells expressing phospho-histone H3 (PH3, Figure 3.5F) as 
compared to control (Figure 3.5E). Furthermore, mKi67 and Ccne1 mRNA levels are 
reduced in cKO pituitaries. This is coincident with an increase in Cdknc1 (p57) mRNA 
(Figure 3.5G), a cell cycle inhibitor shown to be necessary for pituitary progenitors to 
exit the cell cycle before differentiating (Bilodeau, et al. 2009). Together, these data 
indicate that Notch2 is an important regulator of pituitary proliferation at p1. 
 Because we observe decreased proliferation at p1, we examined approximate AL 
volume at p6 to determine how these changes in proliferation may result in changes in 
pituitary size. We find that at p6 the AL of cKO mice (Figures 3.5J and 3.5K) appears 
hypoplastic compared to control (Figures 3.5H and 3.5I). Additionally, the approximate 
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volume of the cKO AL is significantly reduced as compared to control (Figure 3.5L). 
These findings suggest that reduction in Notch2 can lead to a hypoplastic pituitary as 
early as p6.  
Chemical Notch inhibition results in decreased postnatal proliferation in vivo 
In Notch2 cKO mice, we do not observe proliferation defects until after birth, 
indicating Notch signaling may be specifically important for proliferation that occurs 
postnatally. In order to confirm the postnatal changes we observe in Notch2 ckO mice 
are due to direct actions postnatally, we injected mice during early postnatal 
development with the gamma secretase inhibitor DAPT (N-[N-(3,5-Difluorophenacetyl-L-
alanyl)]-S-phenylglycine t-Butyl Ester). DAPT inhibits cleavage of the Notch intracellular 
domain, thus preventing activation of the downstream pathway (Dovey, et al. 2001; 
Sastre, et al. 2001; Geling, et al. 2002). Mice were injected with 100 mg/kg DAPT or 
vehicle control (DMSO) daily between p2 and p4 and pituitaries were harvested 24 
hours after last injection (Figure 3.6A). This time period was chosen because, based on 
expression analysis, many Notch signaling components appear to be most highly 
expressed between p1 and p5. To determine the efficacy of Notch inhibition in DAPT-
injected mice, mRNA levels of the canonical Notch targets Hes1 and Hey1 and the 
putative pituitary-specific Notch target Prop1 were examined in whole pituitaries. We 
see a significant decrease in all targets examined, with Prop1 levels being most highly 
suppressed after DAPT treatment as compared to vehicle-treated controls (Figure 
3.6B).  
 Because Notch signaling is known to be important for proliferation in many 
developing organs and because we observe decreases in proliferation at p1 in Notch2 
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cKO mice, we examined proliferation by quantifying the percent of BrdU positive cells in 
the AL and IL of pituitaries of DAPT-treated mice and compared these values to vehicle 
controls. In vehicle-injected mice there are an average of 5.51%  (+/- 0.20%) of cells 
that are positive for BrdU (Figure 3.6C) as compared to 2.98% (+/- 0.26%) of cells in 
pituitaries of DAPT-treated mice (Figure 3.6D). Additionally, we find a reduction in 
mRNA levels of mKi67, which is present in cells during all phases of the cell cycle, and 
in Ccnd1, which is important for transition from G1 to S phase, in mice treated with 
DAPT (Figure 3.6E). This is coincident with an increase in Cdknc1 (p57) mRNA (Figure 
3.6F). These observations show that Notch signaling contributes to postnatal pituitary 
proliferation in vivo and are similar to those seen in Notch2 cKO mice at p1. 
In vitro chemical Notch inhibition reveals direct effects on the pituitary 
To elucidate whether the effects observed in the in vivo DAPT injection study are 
consistent with direct effects on the pituitary, we employed an in vitro organ culture 
system (Figure 3.6G). We examined whether proliferation in DAPT-cultured pituitaries is 
affected in an analogous manner to that seen in DAPT-injected mice. Similarly, we find 
a significant decrease in mRNA levels of mKi67 in pituitaries treated with DAPT as 
compared to vehicle treated pituitaries after 48h in culture (Figure 3.6H). Taken 
together, the Notch2 cKO and acute DAPT treatment studies implicate Notch signaling 
in maintaining at least a subset of progenitors and allowing their proliferation during 
postnatal development. 
To identify potentially direct targets of Notch signaling, we performed a 6h 
washout assay, using the in vitro explant system. Targets that are altered after DAPT 
treatment, but recover within the 6h period, are considered to be likely direct targets of 
 75 
the Notch signaling pathway (Weng, et al. 2006; Chadwick, et al. 2009; Wang, et al. 
2011). We observe significant reductions in mRNA levels of the Notch targets Hes1, 
Hey1 and Prop1, with Prop1 levels again being the most decreased after culture in the 
presence of DAPT. Six hours after washout, the mRNA levels of the canonical Notch 
targets Hes1 and Hey1 have recovered to levels comparable to those in vehicle-treated 
pituitaries. Prop1 levels recover to levels that are statistically similar to vehicle-treated 
pituitaries, albeit not as complete of a response as Hes1 or Hey1 (Figure 3.6I). This 
further suggests that Prop1 is likely a direct Notch target and show that Notch signaling 
can influence Prop1 expression after birth. 
Loss of Notch2 results in decreased Pit1 cell number and increased POMC number at 
p1 
In addition to its role in progenitor maintenance and proliferation, Notch signaling 
has been shown to be a critical regulator of cell fate in many systems (Ohtsuka, et al. 
2001; Murtaugh, et al. 2003; Patten, et al. 2003; Siveke, et al. 2008). In order to 
determine whether Notch signaling has a similar role in the pituitary, we examined the 
fate of Pit1-lineage cells, which contain GH, TSH and PRL, as well as corticotropes and 
gonadotropes at p1 in control and Notch2 cKO mice. GH is normally expressed in the 
AL of control mice (Figure 3.7A) and appears to be reduced in cKO pituitaries (Figure 
3.7B). TSHβ appears throughout the AL in control mice (Figure 3.7C) and appears to be 
largely unchanged in cKO pituitaries (Figure 3.7D). In parallel, we examined mRNA 
levels of Gh, Tshb and Pou1f11 (Pit1). We observe a significant reduction in cKO 
mRNA levels of Pou1f1 and Gh, with Tshb levels statistically similar between control 
and cKO mice (Figure 3.7Q). To determine if the observed changes in mRNA levels 
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correlates with changes in cell number, we quantified the % of Pit1-positive cells in the 
AL of control and cKO mice. In control mice 44.35% (+/- 1.59%) of AL cells are positive 
for Pit1, compared with only 26.97% (+/- 2.85%) in cKO mice (Figure 3.7T), suggesting 
Notch2 is, at least in part, necessary to obtain the proper number of Pit1-positive cells.  
POMC is expressed in melanotropes in the IL and corticotropes in the AL in both 
control (Figure 3.7E) and cKO (Figure 3.7F) mice and appears to be slightly increased 
in the AL of cKO mice as compared to control. Additionally, we observe a trend towards 
an increase in mRNA levels of Tpit and Pomc, which are present in both corticotropes 
and melanotropes, in cKO mice. To more specifically explore corticotrope and 
melanotrope lineages, we examined expression levels of genes that are specific to each 
cell type (Budry, et al. 2012). We show an increase in levels Crhr1, which is expressed 
in corticotropes, in cKO pituitaries. Conversely, no changes in mRNA levels of Pax7, a 
melanotrope-specific marker, are observed in cKO mice (Figure 3.7R). In order to 
determine if these changes in mRNA are coincident with changes in cell number, we 
quantified the number of POMC-positive cells in the AL. Control mice have 11.87% (+/- 
0.40%) POMC-expressing cells in the AL. cKO mice have a significantly increased 
number of POMC-containing AL cells (15.49% +/- 0.83%) (Figure 3.7T), suggesting that 
Notch2 is an important factor regulating corticotrope number. 
LHβ is found in few cells scattered throughout the ventral pituitary in control mice 
(Figure 3.7G) and the number of LHβ-positive cells does not appear to be altered in 
cKO pituitaries (Figure 3.7H). Although the number of LHβ-immunopositive cells does 
not appear to be changed in cKO mice, Lhb mRNA levels are significantly increased in 
cKO pituitaries as compared to control. Additionally, Nr5a1, a transcription factor 
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expressed only in gonadotropes in the pituitary is significantly increased in cKO at p1, 
while Gnrhr shows a trend towards an increase (Figure 3.7S). To determine if these 
changes in mRNA levels correlate with changes in LHβ-positive cell number, we 
quantified the percentage of AL cells that express this hormone. We find no difference 
between control (2.95% +/- 0.20%) and cKO mice (2.99% +/- 0.08%) (Figure 3.7T), 
suggesting regulation of the gonadotrope cell number is likely independent of Notch2. 
Mice with conditional loss of Notch2 have reduced GH and TSHβ at p6 
In order to examine how loss of Notch2 affects expansion of the pituitary 
hormone lineages during postnatal development, we immunohistochemically examined 
the expression of pituitary hormones at p6. Similar to what was observed at p1, GH 
appears to be reduced in cKO pituitaries (Figure 3.7J) as compared to control pituitaries 
(Figure 3.7I). In contrast to p1, TSHβ appears to be strongly reduced in cKO mice at p6 
(Figure 3.7L) as compared to control mice (Figure 3.7K). POMC is present in the IL and 
AL of control mice (Figure 6M) and appears to be slightly increased in the AL of cKO 
mice (Figure 3.7N), mirroring the qRT-PCR results and cell counts observed at p1. LHβ 
is present in scattered AL cells of control mice (Figure 3.7O) and cKO mice (Figure 
3.7P) and appears similar between the two groups. Taken together, these data show 
that Notch2 is necessary to control the number of Pit1-positive cells and POMC-positive 
cells during postnatal pituitary expansion. 
In order to eliminate the possibility that the reduction in Gh is a result of the 
presence of the Cre transgene alone, we examined Gh mRNA in control mice with 
(Notch2+/+ Foxg1+/cre or Notch2+/fl Foxg1+/cre) and without (Notch2+/+ Foxg1+/+, Notch2+/fl 
Foxg1+/+ or Notch2fl/fl Foxg1+/+) the Cre transgene. No differences were observed 
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between the two groups in Gh levels (Figure 3.8A) at p1. Additionally, although the 
Foxg1 Cre should not be expressed in the developing hypothalamus and thus Notch2 
expression should not be altered there, we examined whether reduced GH expression 
could be due to unexpected alterations in Ghrh in the hypothalamus in the cKO mice. In 
control mice, in situ hybridization reveals Ghrh mRNA is present in cells lateral to the 
third ventricle in the arcuate nucleus (Figure 3.8B). A similar pattern of expression is 
observed for cKO mice (Figure 3.8C). These data suggest that the phenotype of the 
Notch2 cKO mice is likely due to the pituitary intrinsic effects of loss of Notch2.  
Postnatal chemical Notch inhibition results in decreased mRNA levels of Pit1-lineage 
hormones and increased Pomc mRNA levels 
Because alterations in pituitary hormones were observed when Notch2 is lost 
from early embryogenesis, we investigated whether Notch signaling is also specifically 
important for postnatal pituitary cell fate choice. In order to examine this question, we 
injected mice with DAPT daily from p3 through p7 and harvested whole pituitaries on 
p12 in order to allow changes in differentiated cells to manifest (Figure 3.9A). In mice 
treated with DAPT, we observe a significant decrease in mRNA levels of Pou1f1, Prl 
and Tshb. Interestingly, although part of the Pit1 lineage, mRNA levels of Gh are 
unchanged after DAPT treatment. Pomc mRNA levels are increased after DAPT 
treatment, while Lhb mRNA levels appear unaffected (Figure 3.9B). In order to 
determine whether these alterations are maintained after DAPT treatment, we injected 
mice with DAPT daily from p3 through p7 and harvested their pituitaries on p32 (Figure 
3.9C). We show that mRNA levels of Pou1f1 and Prl remain decreased in DAPT-treated 
mice, whereas all other hormones are unchanged (Figure 3.9D). These findings show 
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that Notch signaling is necessary for proper mRNA levels of Pou1f1, Tshb, Prl, and 
Pomc and suggest a role for Notch in postnatal pituitary cell fate choice, similar to what 
was uncovered in the Notch2 cKO mouse. 
 
DISCUSSION 
 Taken together, our studies have defined key roles for Notch signaling during 
postnatal development. We show that Notch signaling is required for pituitary 
proliferation and progenitor maintenance during postnatal pituitary expansion, but 
appears to be less important for these processes during embryonic development. 
Furthermore, during both periods of development, we show that Notch signaling 
regulates the balance between the Pit1 and POMC lineages.   
We have identified Notch2 as an important regulator of postnatal pituitary 
progenitor placement and number. Pituitary stem/progenitor cells contain the markers 
SOX2 and SOX9 and have been shown to contribute to postnatal pituitary homeostasis 
during both normal and stressed conditions  (Rizzoti, et al. 2013; Andoniadou, et al. 
2013). Therefore, it is critical that an appropriate number of progenitor cells are 
maintained. We show that Notch2 cKO mice have progressive loss of this progenitor 
population after birth, suggesting that Notch signaling is necessary for maintenance of 
these cells. Loss of SOX2 in the embryonic pituitary results in impaired proliferation, 
pituitary hypoplasia and a reduction in cells of the Pit1 lineage  (Jayakody, et al. 2012), 
mirroring what is observed in Notch2 cKO mice. Additionally, overexpression of 
activated Notch in POMC-expressing cells results in increased SOX2 expression in the 
IL  (Goldberg, et al. 2011), suggesting Notch may have the ability to induce SOX2 
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expression. Both Sox2 and Sox9 are direct Notch targets in neural progenitors in vivo  
(Li, et al. 2012), indicating the potential for Notch to directly control these factors in the 
pituitary.  
Loss of Notch2 results in differential effects in AL and IL progenitors. IL 
progenitors are misplaced at p1, similar to what is observed with conditional loss of the 
Notch pathway components Numb and Numblike  (Moran, et al. 2011) and are nearly 
absent by p5. This is likely due to the fact that they lack the proper progenitor niche. In 
contrast, AL progenitors appear to be correctly localized but decreased in number by 
p5. These differences may be due to the heterogeneity of progenitor populations 
observed throughout the pituitary  (Garcia-Lavandeira, et al. 2009; Rizzoti. 2010). 
Additionally, we show that Notch2 is not uniformly expressed in all progenitors, which 
may contribute to differences observed in different populations. These differential 
effects in progenitor populations may also be a contributing factor to the changes in 
hormone producing cell number observed at p1, as some lineage-committed or 
intermediate progenitors may have altered ability to expand. 
We show that reductions in Notch2 have little effect on embryonic pituitary 
proliferation, but that Notch2 is required for proliferation during postnatal pituitary 
expansion. This is in contrast to studies showing reduced proliferation in the embryonic 
pituitary of Hes1 knockout mice  (Zhu, et al. 2006; Raetzman, et al. 2007; Kita, et al. 
2007; Monahan, et al. 2009). This indicates that the Hes1 null phenotype may be due to 
factors extrinsic to the pituitary or that the reduced but detectable presence of Hes1 and 
other Notch signaling components, including Notch3, in Notch2 cKO mice is sufficient to 
maintain embryonic proliferation. Additional studies examining pituitary-specific loss of 
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Hes1 will be required to further explore this question. Although we do not observe 
alterations in proliferation in cKO mice at e12.5, we see a striking decrease in 
proliferation at p1. We see a similar reduction in proliferation in mice treated postnatally 
with the chemical Notch inhibitor DAPT. This correlates with studies showing decreased 
proliferation in adult dissociated pituitary cells in vitro when treated with DAPT  (Chen, 
et al. 2006; Tando, et al. 2013). However, it remains unclear if Notch signaling directly 
controls proliferation or alters the ability of stem cells to respond to proliferative signals.   
We show that loss of Notch2 results in alterations in cell fate, a phenomenon that 
has been described in multiple contexts, including pancreatic and central nervous 
system development  (Ohtsuka, et al. 2001; Murtaugh, et al. 2003; Patten, et al. 2003; 
Siveke, et al. 2008). Specifically, after loss of Notch2, we detect a decrease in Pit1 cell 
number. This finding is similar to that observed in a conditional pituitary knockout of 
Rbpj, an essential Notch cofactor  (Zhu, et al. 2006). Additionally, we have extended 
these observations showing that alterations in hormone producing cell number are 
maintained during postnatal expansion in Notch2 cKO mice and that the Pit1 lineage is 
similarly affected after postnatal DAPT treatment. It is likely that the changes observed 
in the Pit1 lineage in both models are due to reductions in Prop1 levels as Prop1 is 
necessary for differentiation of cells of the Pit1 lineage (add reference here). However, it 
is also likely that the levels of Prop1 in Notch2 cKO and DAPT-injected mice are 
sufficient to allow for some expression of Pit1, as we do not observe a complete 
absence of this lineage. Taken together, our results show that reduced levels of Notch2, 
or of Notch signaling components in general, result in specific and incomplete reduction 
in Pit1 and hormones of the Pit1 lineage. This suggests that other signaling pathways or 
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molecules are also important development and function of Pit1 lineage hormones. Such 
factors may include GATA2, which helps to maintain Tshb expression  (Kashiwabara, et 
al. 2009) and Math3, which is required for somatotrope maturation  (Zhu, et al. 2006). 
In addition to the decrease observed in Pit1 lineage cells when Notch is reduced, 
we find that the POMC lineage is also affected by reductions in Notch signaling. In 
Notch2 cKO mice, we observe an increase in the percent of POMC-containing AL cells 
and an increase in mRNA levels of Crhr1, which is restricted to corticotropes, in Notch2 
cKO mice. These changes are paralleled by an increase in Pomc mRNA in mice treated 
with the chemical Notch inhibitor, DAPT. A similar increase in POMC-expressing cells is 
observed in mice with loss of both Hes1 and Prop1 and in mice with pituitary-specific 
loss of Rbpj  (Zhu, et al. 2006; Himes and Raetzman. 2009). Additionally, in order to 
obtain ACTH-producing cells from embryonic stem cells, these cells must first be 
incubated with DAPT  (Suga, et al. 2011). This is confirmed by the observation that 
persistent expression of activated Notch in corticotropes results in POMC repression  
(Goldberg, et al. 2011). Taken together, these data all suggest that Notch signaling 
must be inhibited for corticotrope differentiation to proceed. Interestingly, the IL POMC-
expressing melanotropes appear to be less affected by alterations in Notch signaling in 
our model. This may be due to the fact that we observe no changes in Pax7, a pioneer 
factor that dictates melanotrope fate by altering chromatin accessibility  (Budry, et al. 
2012). Additionally, despite these changes in corticotrope and Pit1 lineage cell number, 
our data suggest the gonadotrope lineage differentiates independently of Notch 
signaling. Taken together, these data strongly suggest that Notch2 may help to regulate 
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the balance between the Pit1 and POMC lineages. This role may be direct or may be a 
result of the altered ability of different progenitor populations to expand. 
Our studies have defined Notch2 as a critical regulator of Prop1 expression. We 
show that loss of Notch2 leads to decreased expression of Prop1 at both e12.5 and p1 
and that in vivo and in vitro exposure to the chemical Notch inhibitor DAPT results in 
strong reductions in mRNA levels of Prop1. A recovery in Prop1 mRNA levels in vitro is 
observed six hours after DAPT washout, mirroring the recovery seen in the canonical 
Notch targets Hes1 and Hey1. Recent work has shown that RBPJ can bind to the first 
intron of the Prop1 gene, further solidifying Prop1 as a direct Notch target  (Zhu, et al. 
2006). Additionally, the phenotype observed in Notch2 cKO mice is similar, although 
less severe, to that observed in Prop1-deficient mice, with both showing a reduction in 
hormones of the Pit1-lineage and inability of the pituitary to appropriately expand after 
birth  (Gage, et al. 1996a; Gage, et al. 1996b; Nasonkin, et al. 2004; Ward, et al. 2005). 
Although some aspects of the phenotype observed when Notch2 is lost are similar to 
that of Prop1 mutants, we do not see increased adhesion and inability of cells to migrate 
out of Rathke’s pouch in Notch2 cKO mice, as is seen in mice with loss of Prop1  
(Ward, et al. 2005). These differences indicate that the levels of Prop1 in Notch2 cKO 
mice may be sufficient to prevent cell migration defects or that other Notch targets are 
able to compensate for defects observed when Prop1 is lost.  
 Genetic causes of CPHD include mutations resulting in hypomorphic SOX2 
expression and loss of function mutations in PROP1 and PIT1  (Wu, et al. 1998; 
Kelberman, et al. 2009; Castinetti, et al. 2012). Our studies show that reductions in 
Notch signaling can result in alterations in expression of all of these factors during 
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embryonic and postnatal development. Furthermore, we show that loss of Notch2 can 
lead to hypoplastic pituitary as early as p6, indicating that the Notch signaling pathway 
is an important regulator of pituitary size and cell fate. Based on these studies, it may be 
advisable to consider whether Notch2 or other members of the Notch signaling pathway 
are altered in patients with CPHD that have no known genetic mutations.  
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Table 3.1. Primers used for qRT-PCR analysis.
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Gene Forward Primer Reverse Primer
Gapdh GGTGAGGCCGGTGCTGAGTATG GACCCGTTTGGCTCCACCCTTC
Dll1 TAACCTCGTTCGAGACCTCAAGGG TGGCACTTGGTGTCACGTTTGC
Jag1 TGTAGCCAGAAAGTGACTGGTTG TGTAGCCAGAAAGTGACTGGTTG
Jag2 TGGACACGAAAGCGCAGGAAAG ACTGGTTGTTGGCGCTCTCATC
Notch1 TTCCATGATTGCCTCCTGCAGTGG CAGGATCAGTGGAGTTGTGCCATCATGCA
Notch2 TGCCAATACTCCACCTCTC TCCACTGACACTGCTTCC
Notch3 GAAGACCCTTGCCACTCAG CCACGGAGACAACGACAG
Notch4 GAGGACCTGGTTGAAGAATTGATC TGCAGTTTTTTCCCTTTTATCCC
Hes1 CTCGCTCACTTCGGACTC CTCGCTCACTTCGGACTC
Hey1 CACGCCACTATGCTCAAT CCTTCACCTCACTGCTCTG
Hey2 GATTCCGAGAGTGCTTGAC AGGTGCTGAGATGAGAGAC
Heyl GGAACAACAGAGAATGAAC CAGCAGTAGTGAGTAACC
Prop1 CCAGAACCGCAGGGCTAAG GGCTATCGGCTGGAGAAGTG
Sox2 GGAGAAAGAAGAGGAGAGAG CTGGCGGAGAATAGTTGG
Sox9 AGCCGACTCCCACATTTCCTCC GAGATTGCCCAGAGTGCTCGCCC
mKi67 CCAGGGATCTCAGCGCAATTACAG GGATAGGACAGAGGGCCACATTC
Ccne1 GGCTCCGACCTTTCAGTCCGC TGGGTCTTGCAAAAACACGGCC
Cdkn1c TCCATCACCAATCAGCCAGCAGAA ATCGCTGGAGGCCAAGCGTTC
Ccnd1 CGCGCGTACCCTGACACCAAT CTCCTCACAGACCTCCAGCATCCA
Pou1f1 AGCTGAGCAGGTCGGAGCTTTGT GGAAGGCTTGCTGTGCTCCCC
Gh AACTGAAGGACCTGGAAGAG GGCGTCAAACTTGTCATAGG
Tshb TGGTCAGGCAGTAGGCACACTCT GTGGGTGGAGAAGAGTGAGC
Tpit GATGCCAAGGAGAGAAACC AGCTTTTCTATCAAATTCACTGA
Pomc GTTACGGTGGCTTCATGACCTC CGCGTTCTTGATGATGGCGTTC
Crhr1 TTTGCTGCCCTGCACCTTTAGAC AGTGACAGAAAGCTGGCTTGGC
Pax7 GCACAGAGGACCAAGCTCAC TGGTGGTGGGGTAGGTAGAG
Gnrhr ATGATGGTCGTGATTAGC ATTGCGAGAAGACTGTGG
Nr5a1 AAATTCCTGAACAACCACAGC GCATCTCAATGAGAAGGTTG
Lhb CCCAGTCTGCATCACCTTCAC GAGGCACAGGAGGCAAAGC
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Figure 3.1. Conditional loss of Notch2 results in decreased Prop1 mRNA at e12.5. Sagittal sections 
of control (A) and cKO (B) e12.5 pituitaries were stained with hematoxylin and eosin and developing 
pituitaries appear roughly the same shape and size. Ki67 immunostaining is similar between control (C) 
and cKO (D) pituitaries. POMC is expressed in few cells in the pituitaries of control (E) and cKO (F) mice. 
The canonical Notch target Hey1 is expressed in the developing pituitary in control mice (G) and appears 
reduced in cKO mice (H). Prop1 is expressed in control mice (I) and appears reduced in cKO mice (J). 
Photos taken at 200x. Scale bar: 50μm. n=4-6.
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Figure 3.2. Characterization of mRNA levels of Notch family members in the pituitary during early 
postnatal development. mRNA levels of Notch ligands (A), receptors (B) and targets (C) were measured 
at e16.5, p1, p5, p10 and p21 and were compared to levels found in adult pituitaries. *:p< 0.05, 
significantly increased compared to adult control. #:p< 0.05, significantly decreased compared to adult 
control. n=4.
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Figure 3.3. Localization of Notch family members in the pituitary at p5. In situ hybridization for Notch2 (A 
and B), Hey1 (C and D) and Hes1 (E and F) reveals that Notch signaling components are mainly localized 
to cells surrounding the pituitary cleft. qRT-PCR comparing control and Notch2 cKO pituitaries at p1 
shows specific and significant reductions in mRNA levels of Notch2 (G), Hes1, Hey1, and Prop1 (H).  *:p< 
0.05. ***:p< 0.001. Scale bar: 50μm.  n=3-4 (in situ hybridization) and n=4 (qRT-PCR).
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Figure 3.4. Loss of Notch2 results in misplacement of pituitary progenitors at p1 and decreased progenitor 
number at p5. SOX2 is expressed at p1 in cells lining the pituitary cleft and in scattered cells in the 
intermediate lobe (IL) and anterior lobe (AL) of control mice (A, C and E). In contrast, in cKO mice, SOX2 
is only present in cells in the dorsal IL and is absent from IL cleft cells (B and D), while AL expression of 
SOX2 appears to be unaffected in cKO mice (B and F). SOX9 follows a similar expression pattern to that 
of SOX2 in control mice (G, I and K). SOX9 is restricted to dorsal IL cells (H and J) and appears to be 
reduced in the AL (H and L) of cKO mice. mRNA levels of Sox2 and Sox9 are reduced in whole pituitaries 
of cKO mice at p1 as compared to control (M). SOX2 is expressed in cells lining the cleft in the AL and 
IL in control mice at p5 (N,P,R). In cKO mice, SOX2 containing cells in the IL and the AL are reduced 
(O,Q,S). In the AL parenchyma, SOX2 cells are seen in clusters in control mice (T) and appear reduced 
in cKO mice (U). SOX9 is also expressed in cells lining the cleft in the AL and IL in control mice (V, X, Z) 
and has similar reductions in cKO mice (W,Y,A’) as those seen with SOX2. In control mice, SOX9 is seen 
in clusters in the AL parenchyma (B’). These clusters are not observed in cKO mice (C’). Photos taken at 
200x (A, B, G, H, N, O, V, W), and 400x (C-F, I-L, P-U and X-C’). White boxes (A, B, G and H) indicate 
where higher magnification photos were taken. Arrows (L, S and A’) indicate SOX9 and SOX2-negative 
cleft cells. Scale bars: 25μm (E, F, K, L) and 50μm (A-D, G-J, N-C’). *:p< 0.05. n=6-8 (histology) and n=4-
9 (qRT-PCR). AL=anterior lobe. IL=intermediate lobe.
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Figure 3.5. Decreased proliferation is observed in mice with conditional loss of Notch2, resulting in a 
hypoplastic pituitary by p6. Ki67 immunoreactive cells are found in the AL and IL of control (A and C) 
pituitaries at p1. The number of Ki67-immunopositive cells appears to be reduced in both lobes of cKO 
(B and D) mice. Phospho-histone H3 (PH3) expression is scattered throughout the pituitary at p1 in 
control (E) mice and is markedly decreased in cKO (F) pituitaries. qRT-PCR in whole pituitaries at p1 
reveals a significant decrease in mRNA levels of mKi67 and Ccne1 and a significant increase in Cdkn1c 
mRNA in cKO mice as compared to controls (G). Hematoxylin and eosin staining reveals a hypoplastic 
AL at p6 in cKO mice (J and K) as compared to control mice (H and I). Volume of AL at p6 is decreased 
in cKO mice. Photos taken at 50x (H-K), 200x (A, B, E and F) and 400x (C and D). White box (A and B) 
indicates where higher magnification photos were taken. Scale bars: 50μm. *:p< 0.05. ***:p<0.001. n=6-7 
(immunohistochemistry), n=4-7 (qRT-PCR) and n=3-4 (AL volume approximation). PL=posterior lobe. 
AL=anterior lobe. IL=intermediate lobe.
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Figure 3.6. Postnatal Notch inhibition results in decreased proliferation and identifies Prop1 as a direct 
target. Experimental design for in vivo DAPT injection (A). Subcutaneous injection with DAPT results in 
a decrease in whole pituitary mRNA levels of Hes1, Hey1 and Prop1 as compared to vehicle-injected 
mouse pituitaries (B). BrdU-positive cells (red) are present throughout the pituitaries of vehicle-treated 
mice (C, 5.51% ± 0.20%) and are significantly reduced (p=0.0001) in pituitaries of DAPT-treated mice 
(D, 2.98% ± 0.26%). mRNA levels of mKi67 and Ccnd1 in whole pituitaries are decreased after DAPT 
injection as compared to vehicle injection (E). Conversely, mRNA levels of Cdkn1c are increased in the 
whole pituitary of DAPT-injected mice (F). Experimental design for in vitro DAPT treatment and DAPT 
washout assay (G). After 48h in culture, mRNA levels of mKi67 are significantly decreased compared to 
vehicle-treated controls (H). mRNA levels of Hes1, Hey1 and Prop1 are reduced after DAPT treatment 
and recover after 6h DAPT washout (I). Photos taken at 100x. Scale bars: 50μm. *:p< 0.05. **:p<0.01. 
***:p<0.001. n=4 (immunohistochemistry), n=5-8 (qRT-PCR in vivo) and n=4-8 (qRT-PCR in vitro).
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Figure 3.7. Conditional loss of Notch2 results in decreased expression of Pit1-lineage hormones and 
increased expression of POMC. GH immunopositive cells are found scattered throughout the AL of control 
(A) mice and appear to be reduced in pituitaries of cKO (B) at p1. TSHβ is localized to the AL of control 
(C) and cKO (D) mice. POMC immunoreactive cells are found in the AL and the IL of control (E) pituitaries 
and appear slightly increased in the AL of cKO mice (F). LHβ expression is confined to the AL and 
appears similar between control (G) and cKO (H) mice. At p6, GH is present in the AL of control (I) mice 
and appears reduced in cKO mice (J). Similarly, TSHβ is strongly reduced in cKO mice (L) as compared 
to control (K). POMC is present in the IL and AL of control mice (M) and appears slightly increased in the 
AL of cKO mice (N). LHβ appears similar between control (O) and cKO (P) pituitaries. qRT-PCR analysis 
at p1 reveals a significant decrease in Pou1f1 (Pit1) and Gh mRNA, but no change in Tshb mRNA 
between control and cKO mice (Q). Additionally, p1 mRNA levels of Tpit and Pomc show a trend towards 
an increase in cKO mice, whereas Crhr1 is significantly increased and Pax7 is unchanged (R). mRNA 
levels of Nr5a1, and Lhb are significantly increased in  pituitaries, while Gnrhr is trending towards an 
increase at p1 (S). The percent of Pit1-, POMC- and LHβ-positive cells in the AL was quantified in control 
and cKO mice and the percent of Pit1-positive cells was found to be deceased in cKO mice, whereas the 
percent of POMC-immunoreactive cells is increased (T). *: p< 0.05. Photos taken at 200x. Scale bars: 
50μm. n=5-7 (histology), n=4-7 (qRT-PCR) and n=3-5 (cell counts). PL=posterior lobe. AL=anterior lobe. 
IL=intermediate lobe.
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Figure 3.8. Foxg1 Cre mice do not display altered pituitary development or ability to influence 
hypothalamic Ghrh neuron number. Gh mRNA levels in whole pituitaries of p1 mice with and without a 
Cre transgene were similar (A). Ghrh mRNA expression is similar in the arcuate nucleus between control 
(B) and cKO (C) mice at p1. Photos taken at 200x. Scale bars: 50μm. n=3 (in situ hybridization) and n=5-
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Figure 3.9. Postnatal chemical Notch inhibition results in decreased mRNA levels of Pou1f1 (Pit1), Prl, 
and Tshb and increased levels of Pomc. Experimental design for in vivo subcutaneous DAPT injection 
(A). mRNA levels of Pou1f1, Prl and Tshb are significantly decreased and mRNA levels of Pomc are 
significantly increased in whole pituitaries after DAPT injection as compared to vehicle-treated mice. 
mRNA levels of Gh and Lhb are unchanged between the two groups (B). Experimental design for in 
vivo subcutaneous DAPT injection longer paradigm (C). mRNA levels of Pou1f1 and Prl are decreased 
in whole pituitaries after DAPT injection as compared to vehicle-treated mice. mRNA levels of all other 
hormones are unchanged between the two groups (D). *: p< 0.05. n=3-5. *: p< 0.05. n=3-5. 
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CHAPTER 4: Notch signaling regulates proliferation and cell fate 
determination genes in the pituitary 
ABSTRACT 
 During embryonic and postnatal development, pituitary progenitors 
proliferate and differentiate in response to internal and external cues. Specific 
factors that are important for regulating these processes remain unclear. 
Previous work shows that Notch signaling components are elevated during 
embryonic and postnatal pituitary development and help to regulate proliferation 
and corticotrope cell number (Chapters 2 and 3). To identify transcriptional 
targets through which Notch regulates these processes, microarray analysis was 
performed to compare the pituitaries of control and Notch2 cKO. Gene ontology 
analysis shows that many of the altered transcripts in Notch2 cKO mice are 
implicated in cell division events, including mitosis, replication and cell cycle 
control. Additionally, we identified a subset of genes that are changed in Notch2 
cKO mice that are important for corticotrope differentiation and signaling. One 
such gene, Hsd11b1, which encodes for the 11β-HSD1, is an important factor in 
regulating local corticosteroid levels, which are known to affect corticotrope 
number. We confirmed that Hsd11b1 is decreased in Notch2 cKO mice and in 
mice or pituitary explants treated postnatally with DAPT, a chemical Notch 
inhibitor. Scanning the Hsd11b1 promoter for candidate regulatory sequences of 
Notch signaling reveals three Hey1 binding sites, suggesting a mechanism by 
which the Notch pathway may control expression of this enzyme. Expression 
analysis shows that Hsd11b1 is expressed at very low levels at e16.5 and 
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increases by p1. Additionally, we show that 11β-HSD1 is mostly present in 
POMC-expressing melanotropes and corticotropes. This study is the first to show 
that Notch signaling can alter Hsd11b1 levels and suggests a mechanism by 
which Notch may influence corticotrope cell number and pituitary proliferation.  
 
INTRODUCTION 
 All pituitary endocrine cells are derived from a common pool of progenitors 
that express the stem cell markers SOX2 and SOX9 (Fauquier, et al. 2008; 
Andoniadou, et al. 2013; Rizzoti, et al. 2013). During early postnatal development, 
these progenitor cells remain highly proliferative and integrate intrinsic and 
extrinsic signals to help them choose between proliferation and endocrine 
differentiation (Gaston-Massuet, et al. 2011; Gremeaux, et al. 2012). Intrinsic 
factors that influence postnatal pituitary proliferation include cell cycle control 
protein Cdk4 (Jirawatnotai, et al. 2004) and Wnt signaling mediator β-catenin 
(Gaston-Massuet, et al. 2011). Pituitary progenitors can also proliferate in 
response to external cues. For example, adult mice that have either been 
adrenalectomized or treated with estrogen have increased pituitary progenitor 
proliferation (Nolan and Levy. 2006; Rizzoti, et al. 2013). Altered external 
hormonal signaling can also lead specific changes in differentiated pituitary 
hormonal cell number. For example, adrenalectomy leads specifically to an 
increased number of corticotropes (Nolan, et al. 2004). Conversely, treatment 
with the glucocorticoid receptor agonist, dexamethasone, results in a reduction in 
corticotrope number (Nolan and Levy. 2006). These changes in corticotrope cell 
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number are a direct reflection of the pituitary’s ability to regulate cell number in 
response to signals from both the hypothalamus and the adrenals. In both 
studies, levels of corticosteroids, which are normally produced by the adrenals 
are altered, leading to a change in pituitary corticotrope number. Our studies 
show that Notch signaling is important for both progenitor proliferation and 
differentiated cell balance, suggesting it may be an important point of integration 
for intrinsic and extrinsic cues. 
Notch signaling is an evolutionarily conserved pathway that functions to 
maintain cells in a progenitor state by repressing transcription of pro-
differentiation factors (Louvi and Artavanis-Tsakonas. 2006). In conjunction with 
this role, reductions in Notch signaling often result in decreased proliferation (van 
Es, et al. 2005). In more rare instances, such as in T-cell acute lymphoblastic 
leukemia, excessive Notch signaling can actively promote proliferation 
(Pancewicz, et al. 2010). Multiple studies have sought to identify direct Notch 
targets that may account for Notch’s influence on proliferation. Specifically, Notch 
signaling has been shown to directly regulate transcription of cell cycle regulatory 
genes, including Ccnd1 (Cohen, et al. 2010) Ccnd3 (Joshi, et al. 2009)  and 
Cdnk1 (Georgia, et al. 2006). These factors are considered direct targets since 
the Notch intracellular domain and cofactor, RBPJ, can bind directly to their 
promoters to influence transcription. Indirect Notch/RBPJ targets, which are 
controlled by binding of downstream Notch effectors (Hes or Hey proteins) at 
their promoters, have also been shown to regulate cell cycle modulators (Murata, 
et al. 2005). In the developing pituitary, loss of the Notch target gene Hes1 
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results in increased expression of the cell cycle inhibitors p21, p27 and p57, 
suggesting that Notch signaling may control similar factors in the pituitary 
(Monahan, et al. 2009). Additionally, mice with conditional loss of Notch2 have 
reduced proliferation and altered levels of cell cycle molecules (Chapter 3). Other 
factors that are regulated by Notch and are important for pituitary proliferation 
have yet to be identified.   
Notch signaling also regulates cell fate choice in multiple systems, 
including the pancreas and the nervous system (Ohtsuka, et al. 2001; Ge, et al. 
2002; Murtaugh, et al. 2003; Siveke, et al. 2008). In the pituitary, reduced levels 
of Notch signaling result in an increased number of corticotropes and a 
decreased number of somatotropes, thyrotropes and lactotropes (Chapter 3). 
Additionally, when Notch is persistently expressed, differentiation of 
melanotropes and corticotropes is inhibited (Chapter 2). Identification of novel 
Notch targets will be important to understand how Notch mediates cell fate 
choices in the pituitary. The following studies were designed as a preliminary 
analysis of the transcriptome regulated by Notch, with the goal of determining the 
mechanism by which Notch influences pituitary proliferation and differentiation.  
 
MATERIALS AND METHODS 
Mice 
 For expression analysis, wildtype male and female mice of mixed genetic 
background were used. For in vitro and in vivo DAPT treatment studies, CD-1 
mice (Charles River, Wilimington, MA), from a breeding colony maintained in our 
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laboratory, were used. For all studies, p1 is considered to be the day of birth. All 
animals were housed in a facility with a 12 hour light-dark cycle and were 
maintained in accordance with the University of Illinois at Urbana-Champaign 
Institutional Animal Care and Use Committee. 
 In order to generate Notch2 cKO mice, Notch2fl/fl mice were obtained from 
Jackson Laboratory (Bar Harbor, ME) and bred to Foxg1+/cre mice, maintained on 
a 129 background, also purchased from Jackson Laboratory. The resulting 
Notch2+/fl, Foxg1+/cre mice were bred to Notch2+/fl, Foxg+/+ littermates to obtain 
cKO animals. To genotype the mice, tail biopsies were obtained and DNA was 
extracted using a hot shot or salt-out method. PCR for the Cre and Notch2 alleles 
was performed as previously described using published primer sequences 
(Chapter 3). 
Agilent Array 
Pituitaries of female control and Notch2 cKO p1 mice were collected and stored 
in RNAlater (Life Technologies, Grand Island, NY) until processing. Two samples 
from female mice of the same genotype were pooled together and RNA was 
extracted using the RNAqueous Micro Kit (Life Technologies). RNA was then 
sent to the Roy G. Carver Biotechnology Center (University of Illinois at Urbana-
Champaign), where cDNA was synthesized and spotted on an Agilent 4x44k 
mouse whole genome array (Agilent Technologies, Santa Clara, CA). Four 
arrays were run for each genotype. Data analysis was performed by Jenny 
Drnevich (Bioinformatics Unit, University of Illinois at Urbana, Champaign).  
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Quantitative Reverse Transcriptase PCR (qRT-PCR) 
RNA was isolated from embryonic and postnatal whole pituitaries using an 
RNAqueous micro kit (Ambion, Austin, TX) as per manufacturers protocol. For 
p21 and adult pituitaries, 0.5µg of RNA was synthesized into cDNA using the 
ProtoScript M-MuLV First Strand cDNA Synthesis Kit (New England Biolabs, 
Ipswich, MA). For e16.5 and p1, p5 and p10 and p12 pituitaries, the total amount 
of RNA from each pituitary was converted into cDNA. A no Reverse 
Transcriptase enzyme control was also prepared and used as a negative control. 
For quantitative RT-PCR 0.1-0.33 µL of cDNA was amplified using gene-specific 
primers and SYBR green mix (Bio-Rad Laboratories, Hercules, CA) on a Bio-Rad 
MyIQ real-time PCR machine. Data were analyzed with the change in cycle 
threshold (∆Ct) value method (Goldberg, et al. 2011), using Gapdh  levels to 
normalize the data. Statistical significance was determined using Student’s t test. 
The sequences of primers used are as follows: Hsd11b1 forward: TCT TCC ATG 
ACG ACA TCC AC, Hsd11b1 reverse: GAG TAG GGA GCA ATC ATA GG, 
Gapdh Forward: GGT GAG GCC GGT GCT GAG TAT G, Gapdh Reverse: GAC 
CCG TTT GGC TCC ACC CTT C. 
DAPT injections 
Beginning at p2, CD1 mice were injected daily for 3 days with 100mg/kg 
DAPT (N-[N-(3,5-Difluorophenacetyl-L-alanyl)]-S-phenylglycine t-Butyl Ester, 
Gamma Secretase Inhibitor IX, Millipore, Billerica, MA) diluted in Dimethyl 
Sulfoxide (DMSO, Sigma-Aldrich, St. Louis, MO) or an equivalent volume of 
DMSO alone. Pituitaries and whole heads were harvested 24h after last injection. 
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For longer-term studies, mice were injected with 100mg/kg DAPT or an 
equivalent volume of DMSO for five days beginning on p3. Pituitaries were 
harvested on p12 or p32. 
Pituitary explant culture and DAPT washout assay 
Pituitaries were dissected from p3 CD1 mice, rinsed with PBS and 
transferred to a 96 well plate. Culture media was made by adding 1% Penicillin 
Streptomycin (Fisher, Fairlawn, NJ) and 10% fetal bovine serum (HyClone, 
Logan, UT) to DMEM/F-12 media (Cellgro, Manassas, VA). 10µM DAPT 
dissolved in DMSO (Millipore) or an equivalent amount of DMSO (Cambridge 
Isotope Laboratories, Andover, MA) was added to the culture media from the 
beginning of culture. After 24h in culture, media was spiked with DAPT or DMSO 
(an equivalent amount to what was added at the beginning of culture) and 
pituitaries were cultured for an additional 24h. 
Immunohistochemistry 
 Whole heads of p1 mice and pituitaries were fixed using a Zinc fixative 
(BD, Franklin Lakes, NJ) and embedded in paraffin for sectioning. Slides were 
deparaffinized and rehydrated. Samples were boiled in 10 mM citrate solution, 
pH6 for 10 minutes and cooled for 15 minutes. Next, all samples were blocked in 
a solution containing 5% normal donkey serum (Jackson Immunoresearch, West 
Grove, PA) diluted in immunohistochemical block, which contains 3% bovine 
serum albumin (Jackson Immunoresearch) and 0.5% TritonX-100 (Sigma Aldrich, 
St. Louis, MO) diluted in PBS. Primary antibodies used were raised against the 
following peptides: 11β-HSD1 (1:100, Abcam, Cambridge, UK), Pax7 
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(1:500,Developmental Studies Hybridoma Bank, University of Iowa), Pit1 (1:2000, 
kind gift of Dr. Simon Rhodes) and POMC (1:1000, Dako, Carpinteria, CA). 
Slides were then incubated with a biotin-conjugated mouse (Pax7) or rabbit 
(POMC, Pit1 and11β-HSD1) secondary antibody. This was followed by 
incubation in a streptavidin-conjugated cy2 or cy3 fluorophore. Biotin and 
streptavidin-conjugated antibodies were purchased from Jackson 
ImmunoResearch and were used at a concentration of 1:500.  Slides were 
counterstained with 4',6-diamidino-2-phenylindole (DAPI, 1:1000, Life 
Technologies, Grand Island, NY) and visualized at 50x 100x, 200x, or 400x 
magnification using a Leica DM2560 microscope. Photographs were taken using 
a Retiga 2000R color camera (Q-Imaging, Surrey, Canada) and acquired using 
Q-Capture Pro software (Q-Imaging). Images were processed using Adobe 
Photoshop CS4 (San José, CA). 
 
RESULTS 
 A microarray comparing control and Notch2 cKO p1 pituitaries was 
performed to identify targets that may contribute to defects observed in 
proliferation and corticotrope cell number in Notch2 cKO mice. 1310 mRNAs 
were found be differentially expressed (p<0.10) between control and Notch2 cKO 
mice. Of these genes, we show that members of the Notch signaling pathway are 
altered, as expected (Table 4.1). In order to identify pathway or global processes 
that may be changed, we used DAVID to group the altered genes using gene 
ontology terms. We find that the majority of top terms changed are related to 
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proliferation. These include DNA replication, cell cycle and M phase. In addition, 
we find alterations in transcripts implicated in cell fate commitment and gland 
development (Table 4.2). Because many of the altered gene products are 
involved in proliferation, we next examined the array data more closely and 
identified a subset of cell cycle-associated genes and genes known to influence 
proliferation that are downregulated when Notch2 is lost (Table 4.3). These 
genes include Cdca2, Cdca5, Cdca, Ccna1, Ccnf , Pcna and Mki67. These 
findings are in agreement with our findings showing that overall proliferation and 
mRNA levels of mKi67 are reduced in Notch2 cKO mice. Future studies 
validating these changes will be performed in an independent sample set. 
Additionally, further work will be aimed at determining whether these genes are 
direct Notch targets in the pituitary.  
Additionally, we have identified a subset of differentially expressed genes 
that may be involved in the regulation of corticotrope differentiation, cell number 
and/or signaling. These factors include Tbx19, Avpr1b and Crhr1, which are 
upregulated and Hsd11b1, which is significantly downregulated in Notch2 cKO 
mice (Table 4.4). Tbx19, Avpr1b and Crhr1 are not generally expressed until 
after corticotrope differentiation has occurred. Therefore, they may be 
upregulated as a byproduct of the increase in corticotrope cell number and are 
not direct factors in the regulation of cell number or differentiation. For this 
reason, we chose to focus the remainder of this study on how alterations in 
Hsd11b1, the gene that encodes for 11β-hydroxysteroid dehydrogenase type 1 
(11β-HSD1), may affect corticotrope cell number and how this gene may be 
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regulated by Notch. 11β-hydroxysteroid dehydrogenase type 1 is an enzyme that 
converts inactive cortisone to its active form, cortisol (11-dehydrocorticosterone 
to corticosterone in mice). This conversion helps to locally increase active cortisol, 
which could then activate the glucocorticoid receptor. Changes in glucocorticoid 
signaling have been shown to affect corticotrope cell number during development, 
(Schmidt, et al. 2009) making this enzyme a possible mechanism by which Notch 
signaling may influence corticotrope number.  
In order to confirm our microarray results showing that Hsd11b1 is 
downregulated in Notch2 cKO mice, we performed quantitative RT-PCR 
comparing control and cKO male and female pituitaries at p1. In agreement with 
the array data, we observe a significant decrease in Hsd11b1 in Notch2 cKO 
mice (Figure 4.1A). Furthermore, when p3 pituitary explant cultures are treated in 
vitro with the Notch inhibitor DAPT for 48 hours, a significant reduction in 
Hsd11b1 is observed (Figure 4.1B). In order to determine if similar effects are 
observed in vivo, we explored whether Hsd11b1 is altered in several paradigms 
in which mice were injected with DAPT. In the first paradigm, (shown in chapter 3, 
figure 3.5A) we show that when mice are injected with 100/mg/kg DAPT on p2, 
p3 and p4 and then harvested on p5, pituitary mRNA levels of Hsd11b1 are 
decreased (Figure 1C).  In contrast, if mice are injected with DAPT daily from p3 
through p7 and harvested on p12 (Figure 4.1D) or p32 (Figure 4.1E), no 
significant change is observed in Hsd11b1 levels, suggesting levels may be able 
to recover during the period in which DAPT is not injected. Together, these data, 
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which examine the effects of both genetic and chemical Notch inhibition, suggest 
that Hsd11b1 is a target of Notch signaling.  
 In order to bioinformatically determine if the Notch cofactor RBPJ or 
canonical Notch targets have the potential to bind to the promoter of Hsd11b1, 
we scanned the Hsd11b1 promoter for known RBPJ, Hes1 or Hey1 binding 
motifs. We identified three Hey1 binding sites within 5kb upstream of the 
Hsd11b1 transcriptional start site (Figure 4.2). We did not identify any potential 
binding regions for either RBPJ or Hes1 using this approach. The discovery of 
these binding sites implies that Hsd11b1 may be downstream of Notch signaling 
and, if so, may be transcriptionally controlled by Hey1. Further work investigating 
this possibility will be a future area of focus in the Raetzman laboratory. 
 In addition to investigating whether Hsd11b1 may be a direct Notch target, 
we have also begun to examine the expression pattern of Hsd11b1 during 
development. This analysis will reveal during which periods the pituitary may be 
sensitive to alterations in Hsd11b1 and other glucocorticoid signaling 
components. We show that the mRNA levels of Hsd11b1 in the pituitary are very 
low (near the limits of detection) at e16.5. They rise by p1 to levels similar to 
those seen in the adult. Interestingly, at p5, a time during which the pituitary is 
undergoing cell expansion and differentiation, the levels of Hsd11b1 are 
significantly increased in comparison to adult. By p9, the levels have decreased 
to levels similar to those observed in the adult and at p21 the levels are, again, 
increased (Figure 4.3). These results suggest that Hsd1b11 begins to become 
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more highly expressed in the pituitary of mice after birth and is expressed at 
dynamic levels throughout postnatal expansion. 
 To determine where in the pituitary 11β-HSD1 is expressed, we performed 
immunohistochemistry in p1 pituitaries. We find that 11β-HSD1 is expressed in 
many cells of the IL and in scattered cells of the AL (Figures 4.4A). The 
expression pattern in the IL appears to closely resemble that of POMC, which is 
expressed in IL melanotropes. Because these cells express the transcription 
factor Pax7 (Budry, et al. 2012), we performed a double immunostain to 
determine whether 11β-HSD1 is expressed in Pax7-expressing cells. We show 
that 11β-HSD1 is expressed in many, but not all, Pax7-expressing cells and does 
not appear to be expressed in any Pax7-negative cells in the IL (Figures 4.4B). In 
order to confirm this observation, we performed colocalization studies with 
POMC. A similar result was observed in the IL, with 11β-HSD1 present in most, 
but not all, POMC-expressing melnanotropes (Figure 4.4C). POMC is also 
expressed in AL corticotropes and we find that the majority of corticotropes 
express 11β-HSD1 (Figure 4.4D). However, there are many 11β-HSD1-positive 
cells in the AL that do not colocalize with POMC. To help determine the identity 
of these cells, we performed double immunohistochehmistry for 11β-HSD1 and 
Pit1, a transcription factor present in somatotropes, thyrotropes and lactotropes. 
We show that a small subset of Pit1-positive cells also express 11β-HSD1 
(Figure 4.4E). These findings show that, at p1, 11β-HSD1 is confined mainly to 
POMC-producing cells, suggesting it acts directly in cells that are responsive to 
glucocorticoid signaling.  
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DISCUSSION 
The pituitary contains multiple endocrine cell types that are all derived 
from a common progenitor population. It is important for function of the gland, 
and thus of pituitary target organs, that the proper number of each cell type is 
formed. If too few or too many of any one population is formed, endocrine 
dysfunction can occur. In Notch2 cKO mice, we observe an increase in the 
number of POMC-expressing corticotropes. Additionally, microarray analysis 
revealed a decrease in expression levels of Hsd11b1. Hsd11b1 encodes the 
11β-HSD1 enzyme, which converts corticosteroids to their active form, allowing 
them to bind to and activate the GR. Previous studies have shown that 
alterations in glucocorticoid signaling can result in changes in corticotrope 
number. Specifically, when GR is lost in POMC-expressing cells in the pituitary, 
an increased number of corticotropes is observed at p6 (Schmidt, et al. 2009).  
Additionally, after adrenalectomy in adult rats, an increase in proliferation and 
corticotrope number is observed (Nolan, et al. 2004). Conversely, when 
adrenalectomized rats are treated with dexamethasone, a GR agonist, an 
increase in ptiuitary apoptosis and a decrease in pituitary proliferation are 
observed (Nolan and Levy. 2006). These data show that the pituitary is able to 
regulate cell number in response to alterations in GR signaling and that the 
corticotrope POMC cell lineage is especially sensitive to these alterations. These 
data may help to explain the phenotype of increased corticotrope number in 
Notch2 cKO mice, as these mice likely have decreased signaling through the GR 
due to decreased levels of Hsd11b1. 
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 11β-HSD1 is a key metabolic enzyme whose dysregulation has been 
implicated in obesity and type 2 diabetes. Mouse models with overexpression of 
11β-HSD1 develop many features of metabolic syndrome, including obesity, 
glucose insensitivity, insulin resistance and hyperlipidemia. Humans with 
metabolic syndrome also exhibit increased levels of 11β-HSD1. Because of 
these observations, 11β-HSD1 is a promising target for the treatment of 
metabolic syndrome and multiple studies have explored the effectiveness of 11β-
HSD1 inhibitors in the clinic [reviewed in (Pereira, et al. 2012)]. Although much 
research has been focused on how this enzyme is dysregulated in metabolic 
syndrome and how it may be a useful target to combat such problems, little is 
known about how 11β-HSD1 expression regulated. We present data showing 
that mice with reduced Notch signaling have significantly reduced levels of 
Hsd11b1, suggesting this pathway may be involved in its regulated expression. 
There is evidence to suggest that, in other systems, levels of Notch signaling can 
influence metabolic processes. Previous studies have shown that both hypo- and 
hyper- activated Notch signaling induce a glycolytic phenotype in breast cancer 
cells (Landor, et al. 2011) and persistent expression of Notch1 promotes insulin 
resistance and induces expression of glucose-6-phosphotase (Valenti, et al. 
2013). These studies show that Notch signaling has the ability to regulate 
multiple metabolic processes and contribute to the notion that Notch may 
regulate metabolic enzymes in the pituitary. 
 We have identified three Hey1 binding sites within 5kb upstream of the 
Hsd11b1 transcriptional start site. These identified sites indicate that Notch target 
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gene products may have the ability to regulate directly the expression of 
Hsd11b1. Hey1 and other canonical Notch downstream effectors have been 
characterized as transcriptional repressors. Therefore, if Hey1 regulates 
Hsd11b1 directly, it would be expected that a reduction in Hey1 would result in 
an increase in Hsd11b1 mRNA levels. Surprisingly, we observe a decrease in 
Hsd11b1 levels when Notch2 is lost and Hey1 is downregulated. This 
relationship suggests that if Hey1 were to directly regulate Hsd11b1, it may be 
acting as a transcriptional activator. Although uncommon, previous studies have 
identified activation roles for Hey1. A study that utilized microarray and chromatin 
immunoprecipitiation identified a subset of targets that are activated by Hey 
proteins (Heisig, et al. 2012). Additionally, Hey1 has been implicated in the 
activation of p53, although the mechanism remains unclear (Huang, et al. 2004; 
Ban, et al. 2008). Transcriptional activation roles for Hes factors, which are also 
Notch targets and members of the basic helix-loop-helix family, have also been 
described. Specifically, in human fibroblast cells, Hes1 activates transcription of 
the human acid-glucosidase (GAA) gene and Hes1 and Hes5 have the ability to 
activate transcription of STAT-3 (Kamakura, et al. 2004). These studies provide 
precedent for the ability of Notch canonical targets to activate other genes. 
 Our data shows that 11β-HSD1 is expressed mainly in corticotropes and 
melanotropes. Previous findings show that Notch signaling components, 
including Hey1, are expressed in cells surrounding the pituitary cleft and in 
scattered AL cells, in a pattern mirroring that of the progenitor markers SOX2 and 
SOX9 (Chapter 3). Because Notch signaling is not likely active in melanotropes 
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and corticotropes, it is unlikely that the downstream Notch effector, Hey1 is able 
to directly regulate Hsd11b1 expression. Future studies will be necessary to 
identify a target which is both under direct Notch control and that can directly 
control corticotrope number. 
 11β-HSD1 is an important metabolic regulator that has been implicated in 
the development and progression of metabolic syndrome. Therefore, 
understanding how this enzyme is controlled is of great importance. We show 
that reductions in Notch signaling results in decreased levels of Hsd11b1, 
suggesting that the Notch signaling pathway may be involved in its regulation. 
Future studies in the Raetzman laboratory will be aimed at determining whether 
Hsd11b1 is a direct target of Notch signaling and how alterations in this enzyme 
and other glucocorticoid signaling factors regulate corticotrope cell number 
during early postnatal pituitary expansion.  
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Table 4.1. Notch ligands, targets and cofactors changed in Notch2 cKO mice, as identified by microarray 
analysis. Four independent samples from control and cKO mice were used to determine significnace. 
Notch	  Signaling	  Pathway	  
	   	  Ligands	   	  	   	  	   	  	  
Gene	   Gene	  Name	   Fold	  Change	  	   p	  value	  
Cntn1	   contactin	  1	   1.739	   0.0220	  
Dll3	   delta-­‐like	  3	   1.427	   0.0231	  
Jag2	   jagged	  2	   1.423	   0.0306	  
Targets	   	  	   	  	   	  	  
Gene	   Gene	  Name	   Fold	  Change	  	   p	  value	  
Dtx4	   deltex	  4	   -­‐1.435	   0.0354	  
Hey1	   hairy/enhancer-­‐of-­‐split	  related	  with	  YRPW	  motif	  1	   -­‐2.045	   0.0499	  
Dtx1	   deltex	  1	   1.327	   0.0665	  
Hes1	   hairy	  and	  enhancer	  of	  split	  1	   -­‐1.293	   0.0810	  
Cofactors	   	  	   	  	   	  	  
Gene	   Gene	  Name	   Fold	  Change	  	   p	  value	  
Rbpjl	  
recombination	  signal	  binding	  protein	  for	  
immunoglobulin	  kappa	  J	  region-­‐like	   -­‐1.234	   0.0744	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Gene	  Ontology	  (GO)	  Terms	  Identified	  as	  Changed	  in	  Notch2	  cKO	  
Mice	  
GO	  Term	   Number	  of	  Changed	  Genes	   p	  value	  
Cell	  Cycle	   81	   1.4x10-­‐13	  
DNA	  replication	   30	   2.7x10-­‐9	  
M	  Phase	   40	   8.0x10-­‐8	  
Cell	  Fate	  Commitment	   18	   0.0027	  
Gland	  Development	   20	   0.011	  
	  
Table 4.2. Pathways, grouped by gene ontology term, found altered in Notch2 cKO mice. Analyzed using 
DAVID (Database for Annotatin, Visualization and Integrated Discovery) bioanalysis software. 
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Proliferation	  
	   	  Gene	   Gene	  Name	   Fold	  Change	  	   p	  value	  
Cdca2	   cell	  division	  cycle	  associated	  2	   -­‐1.368	   0.0373	  
Cdca5	   cell	  division	  cycle	  associated	  5	   -­‐1.498	   7.01x10-­‐14	  
Cdca7	   cell	  division	  cycle	  associated	  7	   -­‐1.442	   0.0282	  
Cdca8	   cell	  division	  cycle	  associated	  8	   -­‐1.248	   0.0638	  
Cdc6	   cell	  division	  cycle	  6	   -­‐1.308	   0.0339	  
Ccna1	   cyclin	  A1	   -­‐1.221	   0.0013	  
Ccnf	   cyclin	  F	   -­‐1.368	   0.0373	  
Cdk1	   cyclin	  dependent	  kinase	  1	   -­‐1.401	   0.0976	  
Pcna	   proliferating	  cell	  nuclear	  antigen	   -­‐1.350	   0.0411	  
Mki67	   antigen	  identified	  by	  monoclonal	  antibody	  Ki67	   -­‐1.619	   0.0321	  
Mybl2	   myeloblastosis	  oncogene-­‐like	  2	   -­‐1.421	   0.0231	  
	  
Table 4.3. Proliferation factors changed in Notch2 cKO mice, as identified by microarray analysis. Four 
independent samples from control and cKO mice were used to determine significnace. 
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Table 4.4. Corticotrope/Melanotrope factors changed in Notch2 cKO mice, as identified by microarray 
analysis. Four independent samples from control and cKO mice were used to determine significnace. 
Corticotrope/Melanotrope	  Differentiation	  or	  Signaling	  
	   	  Gene	   Gene	  Name	   Fold	  Change	  	   p	  value	  
Hsd11b1	   hydroxysteroid	  11-­‐beta	  dehydrogenase	  1	   -­‐2.851	   2.88x10-­‐16	  
Tbx19	   T-­‐Box	  19	   1.540	   0.0231	  
Avpr1b	   arginine	  vasopressin	  receptor	  1B	   1.769	   0.0354	  
Crhr1	   corticotropin	  releasing	  hormone	  receptor	  1	   1.389	   0.0796	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Figure 4.1. Reductions in Notch signaling result in a decrease in Hsd11b1 mRNA levels. Mice with 
conditional loss of Notch2 (Notch2 cKO) have significantly decreased pituitary mRNA levels of Hsd11b1 at 
p1 as compared to control (A). p3 pituitary explants treated with in vitro with 10µM DAPT have signficantly 
reduced mRNA levels of Hsd11b1 as compared to DMSO controls (B). Mice injected subcutaneously with 
100mg/kg DAPT from p2 through p4 and dissected 24 hours later show a significant reduction in Hsd11b1 
pituitary mRNA levels as compared to control (C). Mice injected with 100mg/kg DAPT from p3-p7 and 
harvested on p12 (D) or p32 (E) do not show differences in pituitary mRNA levels of Hsd11b1. n=3-8. 
***:p<0.001.
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Figure 4.2. Schematic showing positions of Hey1 consensus binding sites within 5kb upstream of the 
Hsd11b1 transcriptional start site.
127
0
0.5
2.0
R
el
at
iv
e 
Fo
ld
 C
ha
ng
e
2.5
3.0
3.5
4.0
e16.5 p1 p5 p9 p21 Adult
1.5
1.0
Figure 4.3. Hsd11b1 mRNA begins to be more highly expressed in the mouse pituitary after birth and is 
dynamic throughout postnatal development. All levels are compared to adult. n=3-4. *:p<0.05.
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Figure 4.4. 11β-HSD1 (red) is expressed in melanotropes, corticotropes and few Pit1 l positive 
cells. Coronal section showing 11β-HSD1 expression in the IL and AL of wildtype mice (A). Most IL 
melanotropes contain Pax7 and some, but not all also express 11β-HSD1 (B). 11β-HSD1 is expressed in 
many POMC-containing melanotropes (C). Many, but not all, corticotropes express 11β-HSD1 (D). Few 
Pit1 cells contain 11β-HSD1 (E). Arrows indicate colocalized cells. Photos taken at 200x (A) and 400x (B-
E). Scale bar: 50μm. n=2-3.
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CHAPTER 5: Conclusions/Discussion 
 The pituitary sits at the center of the endocrine system, acting as a relay 
between the hypothalamus and various target organs. Improper development or 
function of the pituitary can lead to many disorders, including combined pituitary 
hormone deficiency (CPHD), Cushing’s syndrome, isolated ACTH deficiency, 
acromegaly and dwarfism (Daly, et al. 2006; Drouin, et al. 2007; Castinetti, et al. 
2012). An understanding of how cell number and cell fate are regulated in the 
pituitary is essential to our understanding of these disorders, as many of them 
are characterized by inappropriate cell number or absence of one or more 
endocrine cell types. The studies described in Chapters 2 through 4 have greatly 
contributed to the understanding of how Notch signaling regulates pituitary cell 
fate and cell number and how alterations in Notch signaling can lead to pituitary 
dysfunction. These findings are summarized in figure 5.1. 
 Notch signaling is an evolutionarily conserved pathway that functions to 
maintain cells in a progenitor state (Kopan and Ilagan. 2009). In many systems it 
has also been shown to regulate the choice between differentiated cell lineages, 
most notably in the nervous system where it influences the choice between 
neurons and glia (Ge, et al. 2002; Patten, et al. 2003). Studies have shown that 
Notch signaling components are expressed in the developing pituitary as early as 
e10.5 (Raetzman, et al. 2004; Zhu, et al. 2006). Mice with loss of the Notch 
effector Hes1 have reduced pituitary proliferation and absence of the 
melanotrope lineage (Raetzman, et al. 2007; Monahan, et al. 2009). When Hes1 
is lost in conjunction with Prop1, early corticotrope differentiation is observed 
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(Himes and Raetzman. 2009). Conversely, Notch2 prevents differentiation when 
overexpressed in gonadotropes (Raetzman, et al. 2006). These studies provide 
insight into the roles of Notch during embryonic pituitary development. The 
present studies seek to build upon and expand these observations by examining 
how Notch signaling acts to regulate proliferation and cell specification in various 
temporal and cell type-specific scenarios. Specifically, we show that persistent 
expression of activated Notch inhibits the differentiation of melanotropes and 
corticotropes and results in dysfunction of the hypothalamic-pituitary-adrenal axis 
(Goldberg, et al. 2011)Chapter 2). Additionally, we show that Notch signaling is 
necessary for postnatal pituitary proliferation, progenitor maintenance and cell 
fate choice (Chapter 3). In order to mechanistically understand how Notch 
influences these processes, we have identified targets of Notch signaling in the 
pituitary and have begun to interpret how these factors function in the pituitary 
(Chapter 4). 
Persistent Notch signaling prevents the differentiation of corticotropes and 
melanotropes (Goldberg, et al. 2011) 
Isolated adrenocorticotropic hormone (ACTH) deficiency is a rare 
condition in which corticotropes either fail to form or fail to produce ACTH. It can 
be caused by mutations in the TPIT (TBX19) gene and the congenital form of the 
disease is often fatal before diagnosis is made (Pulichino, et al. 2003; Vallette-
Kasic, et al. 2004). We show that constitutive expression of activated Notch in 
melanotropes and corticotropes inhibits their differentiation and causes a 
phenotype similar to that seen in patients with isolated ACTH deficiency. 
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Because of this, it may be important to screen patients with ACTH deficiency to 
determine whether mutations in regulatory regions of Notch may be involved in 
this disease. Furthermore, this mouse model may be a good system in which to 
study isolated ACTH deficiency, as it closely mimics the human condition.  
 A major finding of this study is the observation that melanotropes and 
corticotropes fail to regenerate when ablated by persistent Notch expression. We 
show that by p7, the melanotrope-specific transcription factor Pax7 (Budry, et al. 
2012) is no longer expressed and that by p30, the IL is reduced to a very thin 
layer of cells containing only progenitor cell markers. Additionally, we do not 
observe POMC expression in the AL, suggesting a similar elimination of the 
corticotrope population. Interestingly, recent studies have shown that the 
melanotrope population appears to mainly regenerate from progenitor cells, 
whereas corticotropes regenerate using self-duplication (Langlais, et al. 2013). In 
our model, progenitor cells are not affected, yet we still observe failure of 
melanotropes to form and/or expand. It is possible that this is due to rapid 
activation of Notch in newly born melanotropes, which may prevent them from 
differentiating. Future studies aimed at understanding how hormone cells 
regenerate from progenitor cells and/or self-regenerate will be important to our 
understanding of the differences observed in these models.  
Notch2 is necessary for postnatal proliferation, progenitor maintenance 
and cell differentiation 
This study is the first to identify a specific signaling pathway that is 
important during postnatal pituitary expansion. Although studies have shown how 
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pituitary proliferation and progenitor number change during the first three 
postnatal weeks in mice (Carbajo-Pérez and Watanabe. 1990; Gaston-Massuet, 
et al. 2011; Gremeaux, et al. 2012), no study has examined which factors are in 
regulating these processes. Mice with loss of Notch2 at the onset of embryonic 
pituitary development do not display defects until p1. These mice have a 
progressive loss of progenitor cells in the postnatal period, accompanied with a 
reduction in overall pituitary proliferation. Previous studies have shown that the 
number of progenitor cells is elevated during the postnatal period (Carbajo-Pérez 
and Watanabe. 1990; Gaston-Massuet, et al. 2011; Gremeaux, et al. 2012). This 
increased number of progenitors may be necessary to support the large 
expansion that occurs in the pituitary shortly after birth in mice. During this time, it 
is hypothesized that the pituitary begins to respond to external signaling, which is 
thought to influence cell proliferation and specification. We show that Notch 
signaling has a role in maintaining progenitor number during the postnatal period, 
which is not surprising given the large body of work showing that Notch signaling 
is an important progenitor maintenance factor (Ehm, et al. 2010; Aujla, et al. 
2013). It is proposed that these progenitor cells give rise to intermediate 
progenitors, which are responsible for the majority of the proliferation in the 
pituitary. These intermediate progenitors are then thought to differentiate into 
endocrine cells. We observe a reduction in proliferation and which indicates there 
may be a deficit in number or proliferation of this putative intermediate progenitor 
population. Defects in different progenitor populations may also contribute to the 
differences in endocrine cell number that is observed. Future studies aimed at 
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identifying a marker of these intermediate progenitor populations and determining 
how they contribute to postnatal pituitary expansion will be essential to our 
understanding of postnatal pituitary development and the pathways that are 
important during this developmental window.  
An important finding of this study is that Notch2 is dispensable for 
embryonic proliferation. Previous studies have shown that global loss of the 
Notch effector Hes1 results in a decrease in pituitary proliferation (Monahan, et al. 
2009). However, it is unclear from this study whether the defect in proliferation is 
intrinsic to the pituitary or caused by loss of Hes1 in the surrounding tissues, 
namely the hypothalamus which releases signals that are important for pituitary 
development and proliferation (Treier, et al. 1998; Ericson, et al. 1998). Our 
findings suggest that the latter may be true. In agreement with this conclusion, 
mice with pituitary-specific loss of the Notch cofactor Rbpj also show no 
alterations in proliferation at e14.5(Zhu, et al. 2006). Further studies examining 
mice with pituitary-specific and hypothalamic-specific loss of Hes1 will necessary 
to determine how this factor regulates pituitary proliferation. 
We also show that Notch2 helps to regulate the balance of differentiated 
cells in the developing pituitary. Specifically, inhibition of Notch leads to an 
increase in corticotropes and a decrease in cells of the Pit1 lineage. When Notch 
is chemically inhibited in postnatal mice, similar results are found in Pomc and 
Pit1 mRNA levels, suggesting this role is maintained throughout postnatal 
development. These findings are in agreement with studies showing that mice 
with pituitary specific loss of Rpbj have decreased Pit1 expression (Zhu, et al. 
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2006). It is also in agreement with the observation, described in Chapter 2, that 
persistent Notch signaling inhibits the differentiation of corticotropes. This study 
indicates that Notch singling is necessary to inhibit corticotrope differentiation 
and promote Pit1 lineage expansion, acting as a choice point between these two 
lineages. These effects may be direct, with Notch signaling acting in 
differentiating cells to influence their specification. Additionally, Notch may also 
act in progenitor cells to bias them towards distinct intermediate progenitor 
populations.  
Identification of Potential Notch Targets 
In chapter 3, we show that Notch signaling is necessary for postnatal 
pituitary proliferation and progenitor maintenance. In chapters 2 and 3, we also 
highlight a role for Notch signaling in inhibiting the corticotrope lineage and 
promoting the Pit1 lineage. Previous studies have shown that Notch signaling 
may transcriptionally regulate Prop1, which is necessary for transcription of Pit1, 
and thus for GH, TSH and Prl hormone synthesis. We developed a DAPT 
washout assay and used it to validate Prop1 as a bona fide Notch target. This 
finding is important, as human mutations in the first intron of PROP1, where an 
RBPJ consensus sequence is found, can lead to CPHD (Godi, et al. 2012). The 
confirmation that Notch signaling likely regulates Prop1 expression provides 
clues as to how a pathway, like Notch, that is necessary for many aspects of 
embryonic development, can have a tissue specific effect. 
In order to extend the findings in Chapters 2 and 3 and to identify novel 
Notch targets in the pituitary, we performed a microarray comparing control and 
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Notch2 cKO pituitaries. Many of the genes identified by this array are involved in 
various aspects of cell proliferation. This includes factors that are involved in 
mitosis, cell cycle progression and replication. We also identified changes in 
genes involved in pituitary cell differentiation. Of these we identified changes in 
factors that may regulate corticotrope number. These genes are of specific 
interest since we show Notch is important to inhibit corticotrope differentiation. 
Specifically, our array revealed a significant reduction in Hsd11b1 when Notch2 
is lost the pituitary. The Hsd11b1 gene encodes for the protein 11β-HSD1, which 
is necessary for the conversion of inactive corticosteroids to their active forms. In 
late prenatal and early postnatal development, the pituitary is thought to begin to 
respond to external cues from the hypothalamus and its target organs. 
Reductions in Hsd11b1 would decease effective glucocorticoid signaling in the 
pituitary, as there would be a reduction in active corticosteroids, which bind to 
and activate the glucocorticoid receptor (GR). Loss of the GR in the pituitary 
results in an increase in corticotrope number, whereas an increased GR leads to 
deceased ACTH production (Reichardt et al, 2000, Schmidt et al, 2009). We 
hypothesize that reductions in Hsd11b1 levels in Notch2 cKO mice lead to 
deceased glucocorticoid signaling and increased corticotrope number.  
Although Notch has been most studied for its roles in progenitor 
maintenance and cell fate choice, there is precedent to believe that Notch 
signaling is crucial for the regulation of metabolic processes, including insulin 
sensitivity and glycolysis (Landor et al, 2011, Valenti et al, 2013). Understanding 
the extent to which Notch controls Hsd11b1 and how this factor is important for 
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pituitary development and function are important new areas of research in our 
laboratory. Furthermore, we are investigating the possibility that of whether Notch 
influences expression of Hsd11b1 in other important metabolic organs, such as 
the liver. These studies will be another area of focus in the Raetzman laboratory 
and will contribute to a more global understanidng of Hsd11b1 regulation and 
function.  
Overall Conclusions 
 The studies presented in Chapters 2-4 have greatly expanded our 
understanding of the role of Notch signaling throughout pituitary development. 
Specifically, this work is the first to define a role for this pathway in postnatal 
pituitary expansion. In doing so, we have identified the first signaling pathway to 
be active during this period, which is an emerging area of research in the pituitary 
development field. Each of the mouse models presented throughout this work 
represent valuable tools to further explore remaining questions. These questions 
include, but are not limited to, how isolated ACTH deficiency affects development 
of other cell types in the pituitary, how progressive loss of pituitary progenitors 
can lead to hypopituitarism and how glucocorticoid signaling alterations can 
affect corticotrope cell number. These areas of research are potential avenues 
that can be explored in the future.  
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Figure 5.1 Summary of key findings. Our studies show that Notch2 is necessary for postnatal progenitor 
maintenance and proliferation. Additionally, gain and loss of function models reveal that Notch signaling 
promotes the Prop1/Pit1 lineage and inhibits the corticotrope/melanotrope lineage, thus regulating 
differentiated cell number in the developing pituitary.
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